<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Nanomedicine</journal-id><journal-id journal-id-type="iso-abbrev">Int J Nanomedicine</journal-id><journal-id journal-id-type="pmc-domain-id">616</journal-id><journal-id journal-id-type="pmc-domain">intjnano</journal-id><journal-id journal-id-type="publisher-id">ijn</journal-id><journal-title-group><journal-title>International Journal of Nanomedicine</journal-title></journal-title-group><issn pub-type="ppub">1176-9114</issn><issn pub-type="epub">1178-2013</issn><publisher><publisher-name>Dove Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11590659</article-id><article-id pub-id-type="pmcid-ver">PMC11590659.1</article-id><article-id pub-id-type="pmcaid">11590659</article-id><article-id pub-id-type="pmcaiid">11590659</article-id><article-id pub-id-type="pmid">39600411</article-id><article-id pub-id-type="doi">10.2147/IJN.S483626</article-id><article-id pub-id-type="publisher-id">483626</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Toxoplasma gondii-Derived Exosomes: A Potential Immunostimulant and Delivery System for Tumor Immunotherapy Superior to Toxoplasma gondii</article-title><alt-title alt-title-type="running-authors">Zhao et al</alt-title><alt-title alt-title-type="running-title">Zhao et al</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Zhao</surname><given-names initials="LX">Lai-Xi</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="ft0001" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Sun</surname><given-names initials="Q">Qiong</given-names></name><xref rid="aff0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="ft0001" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Wang</surname><given-names initials="C">Chong</given-names></name><xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="ft0001" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="JJ">Jia-Jia</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yan</surname><given-names initials="XR">Xiao-Rong</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Shao</surname><given-names initials="MC">Meng-Ci</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yu</surname><given-names initials="L">Li</given-names></name><xref rid="aff0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0263-6489</contrib-id><name name-style="western"><surname>Xu</surname><given-names initials="WH">Wen-Hua</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="an0001" ref-type="corresp"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0004-9499-0451</contrib-id><name name-style="western"><surname>Xu</surname><given-names initials="R">Rui</given-names></name><xref rid="aff0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><aff id="aff0001"><label>1</label><institution>College &amp; Hospital of Stomatology, Anhui Medical University, Key Laboratory of Oral Diseases Research of Anhui Province</institution>, <addr-line>Hefei</addr-line>, <addr-line>230032</addr-line>, <country>People&#8217;s Republic of China</country></aff><aff id="aff0002"><label>2</label><institution>Department of Stomatology, Anhui Province Direct Subordinate Hospital</institution>, <addr-line>Hefei</addr-line>, <addr-line>230601</addr-line>, <country>People&#8217;s Republic of China</country></aff><aff id="aff0003"><label>3</label><institution>Department of Microbiology and Parasitology, School of Basic Medical Sciences, Anhui Medical University, Anhui Province Key Laboratory of Zoonoses, The Provincial Key Laboratory of Zoonoses of High Institutions in Anhui</institution>, <addr-line>Hefei</addr-line>, <addr-line>Anhui Province</addr-line>, <addr-line>230032</addr-line>, <country>People&#8217;s Republic of China</country></aff></contrib-group><author-notes><corresp id="an0001">Correspondence: Wen-Hua Xu; Rui Xu, Email xuwenhua@ahmu.edu.cn; dentistxr@126.com</corresp><fn id="ft0001"><label>*</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date pub-type="epub"><day>22</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>19</volume><issue-id pub-id-type="pmc-issue-id">452358</issue-id><fpage>12421</fpage><lpage>12438</lpage><history><date date-type="received"><day>20</day><month>6</month><year>2024</year></date><date date-type="accepted"><day>23</day><month>10</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>22</day><month>11</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>26</day><month>11</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-01-05 00:25:50.850"><day>05</day><month>01</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2024 Zhao et al.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Zhao et al.</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref><license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution &#8211; Non Commercial (unported, v3.0) License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="ijn-19-12421.pdf"/><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="correction-forward" xml:lang="en" xlink:title="correction" vol="19" journal-id="Int J Nanomedicine" journal-id-type="nlm-ta" ext-link-type="pmc" xlink:href="PMC11687316"><article-title>Toxoplasma Gondii-Derived Exosomes: A Potential Immunostimulant and Delivery System for Tumor Immunotherapy Superior to Toxoplasma Gondii [Corrigendum]</article-title><volume>19</volume><date><day>27</day><month>12</month><year>2024</year></date><fpage>14019</fpage><lpage>14020</lpage><source>International Journal of Nanomedicine</source><pub-id pub-id-type="doi">10.2147/IJN.S513024</pub-id><pub-id pub-id-type="pmcid">PMC11687316</pub-id><pub-id pub-id-type="pmid">39742096</pub-id></related-article><abstract><title>Abstract</title><p>Immunotherapies such as immune checkpoint blockade (ICB) therapy and chimeric antigen receptor T-cell (CAR-T) therapy have ushered in a new era of tumor treatment. However, most patients do not benefit from immunotherapy due to limitations such as narrow indications, low response rates, and high rates of adverse effects. <italic toggle="yes">Toxoplasma gondii</italic> (<italic toggle="yes">T. gondii</italic>), a specialized intracellular protozoan, can modulate host immune responses by inhibiting or stimulating cytokines. The ability of <italic toggle="yes">T. gondii</italic> to enhance an organism&#8217;s immune response was found to have a direct anti-tumor effect and enhance the sensitivity of patients with tumors to ICB therapy. However, the application of <italic toggle="yes">T. gondii</italic> for tumor therapy faces several challenges, such as biosafety concerns. Exosomes, a subtype of extracellular vesicle that contains active components such as proteins, nucleic acids, and lipids, have become effective therapeutic tools for various diseases, including tumors. Parasites, such as <italic toggle="yes">T. gondii</italic>, mediate the communication of pathogens with immune cells and modulate host cellular immune responses through exosomes. Growing evidence indicates that <italic toggle="yes">T. gondii</italic>-derived exosomes mediate communication between pathogens and immune cells, modulate host immune responses, and have great potential as new tools for tumor therapy. In this review, we highlight recent advances in isolation and identification techniques, profiling analysis, host immunomodulatory mechanisms, and the role of <italic toggle="yes">T. gondii</italic>-derived exosomes in tumor immunotherapy. Additionally, we emphasize the potential of <italic toggle="yes">T. gondii</italic>-derived exosomes as delivery platform to enhance anti-tumor efficacy in combination with other therapies. This review proposes that T. gondii-derived exosomes may serve as a novel tool for tumor immunotherapy owing to their ability to activate host immune function and properties such as high modifiability, stability, and low toxicity. This work will assist in promoting the application of parasite exosomes in tumor therapy.</p></abstract><abstract abstract-type="graphical"><title>Graphical Abstract</title><p>
<fig position="anchor" id="uf0001" orientation="portrait"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" content-type="print-only" position="float" orientation="portrait" xlink:href="IJN-19-12421-g0001.jpg"/></fig>
</p></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd><italic toggle="yes">Toxoplasma gondii</italic></kwd><kwd>exosomes</kwd><kwd>tumor</kwd><kwd>immune regulation</kwd><kwd>immunotherapy</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution>supported by the Research Fund of Anhui Institute of Translational Medicine (2023zhyx-C90), the Basic and Clinical Cooperative Research and Promotion Program</institution></institution-wrap></funding-source></award-group><funding-statement>This work was supported by the Research Fund of Anhui Institute of Translational Medicine (2023zhyx-C90), the Basic and Clinical Cooperative Research and Promotion Program of Anhui Medical University (2023xkjT046), the National Natural Science Foundation of China (82072304), and the Health Research Program of Anhui (AHWJ2022b001).</funding-statement></funding-group><counts><fig-count count="6"/><ref-count count="142"/><page-count count="18"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY-NC</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s0001"><title>Introduction</title><p>Tumors are serious threats to human health and are important obstacles to increasing human life expectancy.<xref rid="cit0001" ref-type="bibr">1</xref> Traditional tumor treatments focus on directly killing tumors through physical removal, chemotherapeutic drugs, or radiation,<xref rid="cit0002" ref-type="bibr">2</xref>,<xref rid="cit0003" ref-type="bibr">3</xref> which have poor efficacy in advanced tumors and side effects on vital organs.<xref rid="cit0004" ref-type="bibr">4</xref> In recent years, immunotherapies have emerged rapidly and have provided new pathways for tumor treatment.<xref rid="cit0004" ref-type="bibr">4</xref> Immunotherapies, including cancer vaccines,<xref rid="cit0005" ref-type="bibr">5</xref> chimeric antigen receptor T-cell (CAR-T) therapy,<xref rid="cit0006" ref-type="bibr">6</xref> nonspecific immunomodulator therapy,<xref rid="cit0007" ref-type="bibr">7</xref> and immune checkpoint blockade (ICB) therapy,<xref rid="cit0008" ref-type="bibr">8</xref>,<xref rid="cit0009" ref-type="bibr">9</xref> intervene in multiple stages of tumor immune evasion by activating host effector T cells and enhancing anti-tumor immune responses, thereby achieving treatment of or even curing tumors.<xref rid="cit0010" ref-type="bibr">10</xref> However, immunotherapies are in the early stages of development and have several shortcomings. The low clinical response rate leaves a large number of patients without benefit.<xref rid="cit0011" ref-type="bibr">11</xref>,<xref rid="cit0012" ref-type="bibr">12</xref> The tumor location is an important factor affecting anti-tumor strategies,<xref rid="cit0013" ref-type="bibr">13</xref> but current tumor immunotherapies are generally not organ-specific, leading to various adverse effects, including central system complications,<xref rid="cit0014" ref-type="bibr">14</xref> cytotoxicity,<xref rid="cit0015" ref-type="bibr">15</xref> and inflammation.<xref rid="cit0016" ref-type="bibr">16</xref> Therefore, new strategies for implementing tumor immunotherapy to improve efficacy and safety remain to be explored.</p><p><italic toggle="yes">Toxoplasma gondii</italic> (<italic toggle="yes">T. gondii</italic>) is an obligate intracellular eukaryotic parasite able to infect humans and other warm-blooded animals. <italic toggle="yes">T. gondii</italic> invades organisms and repeatedly proliferates in infected cells, leading to massive host cell destruction and causing disease.<xref rid="cit0017" ref-type="bibr">17</xref>,<xref rid="cit0018" ref-type="bibr">18</xref> In recent years, the role of <italic toggle="yes">T. gondii</italic> in modulating host immunity and anti-tumor activity has attracted widespread attention. Numerous studies have indicated that <italic toggle="yes">T. gondii</italic> parasitizes the host and induces vigorous immune responses, which have anti-tumor effects.<xref rid="cit0019" ref-type="bibr">19</xref> This effect results from the ability of <italic toggle="yes">T. gondii</italic> to activate antigen processing, antigen presentation, and tumor antigen-specific CD8<sup>+</sup> T cells.<xref rid="cit0020" ref-type="bibr">20</xref>,<xref rid="cit0021" ref-type="bibr">21</xref> Despite numerous studies confirming the potential of <italic toggle="yes">T. gondii</italic> for immunomodulatory and anti-tumor applications, several serious obstacles to live <italic toggle="yes">T. gondii</italic> use as a clinical tumor therapeutic tool exist. First, <italic toggle="yes">T. gondii</italic> must be cultured in living cells to maintain its activity and must be isolated and extracted before use, which greatly increases the time and capital costs. Secondly, directly using live parasites and products for treatment involves biosafety concerns and ethical issues. Live replicating <italic toggle="yes">T. gondii</italic> strains are unlikely to be suitable for tumor therapy, as tumor patients are immunocompromised and thus more vulnerable to infection. Once a nosocomial <italic toggle="yes">T. gondii</italic> infection occurs, it may lead to a variety of adverse effects in the patients. Symptoms such as dizziness and vomiting in milder cases, and retinal necrosis in more serious cases.<xref rid="cit0022" ref-type="bibr">22</xref> In contrast, non-replicating attenuated <italic toggle="yes">T. gondii</italic> strains are more likely to be used for tumor therapy.<xref rid="cit0023" ref-type="bibr">23</xref> However, the attenuated <italic toggle="yes">T. gondii</italic> strains are significantly inhibited in their ability to replicate by special processing, making them difficult to produce in large quantities. Both of their treatments are often invasive, with unpredictable risks of nosocomial <italic toggle="yes">T. gondii</italic> infection.<xref rid="cit0024" ref-type="bibr">24</xref> Therefore, safer, more convenient, and more cost-effective tumor immunotherapy strategies based on <italic toggle="yes">T. gondii</italic> need to be developed.</p><p>Exosomes are nanoscale membrane-bound vesicles formed by phospholipid bilayers encapsulating various components,<xref rid="cit0025" ref-type="bibr">25</xref> that include membrane proteins, metabolic enzymes, cytoplasmic and nuclear proteins, signaling molecules, a variety of nucleic acids,<xref rid="cit0026" ref-type="bibr">26</xref> lipids, and metabolites.<xref rid="cit0027" ref-type="bibr">27</xref>,<xref rid="cit0028" ref-type="bibr">28</xref> Exosomes interact with receptor cells by directly signaling through ligand/receptor interactions or enter receptor cells and regulate receptor cell function by membrane fusion, endocytosis, and macropinocytosis.<xref rid="cit0029" ref-type="bibr">29</xref>,<xref rid="cit0030" ref-type="bibr">30</xref> Exosomes of different origins play distinct roles in normal physiological processes such as the immune response, cell proliferation, and inflammation, as well as in various stages of disease, such as tumors.<xref rid="cit0031" ref-type="bibr">31</xref>,<xref rid="cit0032" ref-type="bibr">32</xref> Exosomes naturally, abundantly, and stably exist in a series of body fluid samples, contain specific substances derived from parental cells such as tumor cells, and their detection is simpler and more specific than that of traditional tumor markers. Thus, exosomes show great potential in tumor body fluid biopsy techniques.<xref rid="cit0033" ref-type="bibr">33</xref> Exosomes are also characterized by low toxicity and immunogenicity, and artificially modified engineered exosomes have become a focus of attention as loaded tumor-targeted drug delivery vehicles and cancer vaccines.<xref rid="cit0034" ref-type="bibr">34</xref>,<xref rid="cit0035" ref-type="bibr">35</xref> Recently, research has shown that parasites such as <italic toggle="yes">T. gondii</italic> can secrete exosomes, facilitating communication with host cells.<xref rid="cit0036" ref-type="bibr">36</xref>,<xref rid="cit0037" ref-type="bibr">37</xref>
<italic toggle="yes">T. gondii</italic>-derived exosomes can regulate host immune responses by inducing macrophage polarization and stimulating T cells.<xref rid="cit0038" ref-type="bibr">38</xref>,<xref rid="cit0039" ref-type="bibr">39</xref> Compared with live <italic toggle="yes">T. gondii, T. gondii</italic>-derived exosomes have significant advantages in terms of biosafety and convenience. Thus, <italic toggle="yes">T. gondii</italic>-derived exosomes have great potential as novel tools for tumor treatment.</p><p>Hence, in this paper, we highlight recent advances in isolation, profiling analysis, and host immunomodulatory mechanisms of <italic toggle="yes">T. gondii</italic>-derived exosomes and the role of <italic toggle="yes">T. gondii</italic>-derived exosomes in tumor immunotherapy. Additionally, we emphasize the potential of <italic toggle="yes">T. gondii</italic>-derived exosomes as delivery platform to enhance anti-tumor efficacy in combination with other therapies. This review will assist in promoting the application of parasite exosomes in tumor therapy.</p></sec><sec id="s0002"><title>Immunomodulatory and Anti-Tumor Effects of Toxoplasma gondii</title><sec id="s0002-s2001"><title>Toxoplasma gondii</title><p><italic toggle="yes">T. gondii</italic> is one of the most common parasites worldwide, infecting nearly one-third of the global population. <italic toggle="yes">T. gondii</italic> invades organs such as the heart through the circulatory system, resulting in chronic infection, and is able to cross biologically restrictive barriers such as the blood&#8210;brain barrier (BBB) and placental barrier to enter immune-privileged sites.<xref rid="cit0040" ref-type="bibr">40</xref>,<xref rid="cit0041" ref-type="bibr">41</xref> Although <italic toggle="yes">T. gondii</italic> infection is asymptomatic or presents with recurrent ocular lesions, lymphadenopathy, etc, in most immunocompetent individuals, immunocompromised individuals can develop life-threatening central nervous system infections after repeated chronic infections.<xref rid="cit0040" ref-type="bibr">40</xref>,<xref rid="cit0042" ref-type="bibr">42</xref> Studies have consistently shown the immunomodulatory and anti-tumor functions of <italic toggle="yes">T. gondii</italic>. In the 1970s, researchers reported the phenomenon of growth restriction of solid tumors in mice infected with <italic toggle="yes">T. gondii</italic>,<xref rid="cit0043" ref-type="bibr">43</xref>,<xref rid="cit0044" ref-type="bibr">44</xref> which attracted widespread attention. Subsequently, studies on <italic toggle="yes">T. gondii</italic> and its products have increased, further revealing the immunomodulatory and anti-tumor effects of <italic toggle="yes">T. gondii</italic>.</p></sec><sec id="s0002-s2002"><title>Toxoplasma gondii-Mediated Immune Regulation</title><p><italic toggle="yes">T. gondii</italic> triggers innate immune responses mediated by macrophages, dendritic cells, neutrophils, monocytes, and natural killer (NK) cells during the acute phase of host infection.<xref rid="cit0045" ref-type="bibr">45</xref> Subsequent generation of specific immune responses against <italic toggle="yes">T. gondii</italic> infection relies on cells such as NK cells, CD4<sup>+</sup> T cells, and CD8<sup>+</sup> T cells, which produce interferon-&#947; (IFN-&#947;).<xref rid="cit0042" ref-type="bibr">42</xref>,<xref rid="cit0046" ref-type="bibr">46</xref> Innate immunity serves as the first defense of the host after infection with pathogens. As an important part of innate immunity, Toll-like receptors (TLRs) recognize microbial components of pathogen-associated molecular patterns (PAMPs) and initiate subsequent immune responses.<xref rid="cit0047" ref-type="bibr">47</xref> After infection of the host by <italic toggle="yes">T. gondii</italic>, Profilin-like proteins, which can be recognized by TLR11 and TLR12 of the TLR family in mice, are released and ultimately induce the production of interleukin 12 (IL-12) in mouse dendritic cells.<xref rid="cit0048" ref-type="bibr">48</xref>,<xref rid="cit0049" ref-type="bibr">49</xref> A significant reduction in IL-12 production by dendritic cells can be observed in <italic toggle="yes">T. gondii</italic>-infected mouse models after knocking out important molecules in TLR-related pathways.<xref rid="cit0050" ref-type="bibr">50</xref> TLR11 and TLR12 are not expressed by human genes; however, human TLR7 and TLR9 can recognize RNA and DNA derived from <italic toggle="yes">T. gondii</italic>, respectively,<xref rid="cit0051" ref-type="bibr">51</xref> and may accordingly induce host cells to produce high levels of proinflammatory cytokines, including IL-12 and TNF-&#945;. IL-12 produced by dendritic cells, macrophages, etc, induces massive proliferation of NK cells,<xref rid="cit0052" ref-type="bibr">52</xref> CD4<sup>+</sup> T cells, and CD8<sup>+</sup> T cells against <italic toggle="yes">T. gondii</italic> infection (<xref rid="f0001" ref-type="fig">Figure 1</xref>).<xref rid="cit0053" ref-type="bibr">53</xref>,<xref rid="cit0054" ref-type="bibr">54</xref> In addition to these cells, antigen-presenting cells such as monocytes also play an important role in <italic toggle="yes">T. gondii</italic> infection. Upon recognition of <italic toggle="yes">T. gondii</italic> antigens by these antigen-presenting cells, genes encoding chemokines, such as CCL2 and CXCL2, are induced, resulting in massive production of chemokines that drive neutrophils and monocytes toward infected sites.<xref rid="cit0055" ref-type="bibr">55</xref> Furthermore, innate lymphoid cells Group 1 (ILCs1), including NK cells, produce Th1-type cytokines, such as IFN-&#947; and tumor necrosis factor-&#945; (TNF-&#945;), to counteract <italic toggle="yes">T. gondii</italic> infections via the oral route.<xref rid="cit0056" ref-type="bibr">56</xref> The mechanisms described above favor the organism over <italic toggle="yes">T. gondii</italic> infection, and the potential application of this host immunomodulatory capacity due to <italic toggle="yes">T. gondii</italic> infection in tumor therapy has drawn the attention of researchers.
<fig position="float" id="f0001" fig-type="figure" orientation="portrait"><label>Figure 1</label><caption><p><italic toggle="yes">Toxoplasma gondii</italic>-mediated immune regulation. After infection of the host cells by <italic toggle="yes">T. gondii</italic>, Profilin-like proteins are released. When Profilin-like proteins are transmitted to immune cells, such as dendritic cells, they can be recognized by TLR11 and TLR12 and ultimately induce the production of interleukin 12 (IL-12). In addition, TLR7 and TLR9 can recognize RNA and DNA from <italic toggle="yes">T. gondii</italic>, respectively, and accordingly induce immune cells, such as dendritic cells, to produce pro-inflammatory cytokines, including IL-12, which induces the massive proliferation of NK cells, CD4<sup>+</sup> T cells, and CD8<sup>+</sup> T cells to protect against <italic toggle="yes">T. gondii</italic> infection.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" content-type="print-only" position="float" orientation="portrait" xlink:href="IJN-19-12421-g0002.jpg"/></fig></p></sec><sec id="s0002-s2003"><title>Toxoplasma gondii and Tumor Immunotherapy</title><p><italic toggle="yes">T. gondii</italic> triggers a vigorous immune response in the host to control self-replication and facilitate its survival and proliferation within host. Such vigorous immune responses can also inhibit the progression of tumors (<xref rid="f0002" ref-type="fig">Figure 2</xref>).<xref rid="cit0057" ref-type="bibr">57</xref> After infecting host immune cells, <italic toggle="yes">the T. gondii</italic> Me49 strain induces the production of certain soluble factors that exert strong and systemic anti-tumor angiogenic effects, leading to severe hypoxia within the tumor tissues, which in turn inhibits the growth of B16F10 melanoma cells in experimental animal models.<xref rid="cit0058" ref-type="bibr">58</xref> A subsequent study found that the survival rate of Lewis lung carcinoma-loaded mice significantly increased after infection with the <italic toggle="yes">T. gondii</italic> Me49 strain. In this study, researchers not only observed significant inhibition of tumor angiogenesis in mice but also significant increases in IFN-&#947;-related mRNA expression levels, CD8<sup>+</sup> T-cell percentages, and cytotoxic T lymphocyte (CTL) counts, suggesting that the <italic toggle="yes">T. gondii</italic> Me49 strain achieves anti-tumor effects by modulating host immunity.<xref rid="cit0059" ref-type="bibr">59</xref> Recently, another study found that the <italic toggle="yes">T. gondii</italic> Me49 strain can stimulate dendritic cells to produce exosomes, which achieve inhibition of tumor growth in hormonal mice by suppressing macrophage polarization toward the M2 type.<xref rid="cit0060" ref-type="bibr">60</xref> In addition to the <italic toggle="yes">T. gondii</italic> Me49 strain, researchers have developed the <italic toggle="yes">T. gondii</italic> nonreplicating avirulent uracil auxotroph vaccine strain (<italic toggle="yes">CPS</italic>). Uridine-5&#8217;-mono-phosphate (UMP) is necessary for nucleic acid synthesis by <italic toggle="yes">T. gondii</italic>. UMP production can be blocked by blocking <italic toggle="yes">T. gondii</italic> synthetic pyrimidines, which leads to the inability of <italic toggle="yes">T. gondii</italic> replication. Modified strains become <italic toggle="yes">T. gondii CPS</italic> strains characterized by low toxicity.<xref rid="cit0023" ref-type="bibr">23</xref>,<xref rid="cit0061" ref-type="bibr">61</xref> After treatment with the <italic toggle="yes">T. gondii CPS</italic> strain, B16F10 melanoma-loaded mice showed significantly increased counts and activity of CD8<sup>+</sup> T cells, while primary tumors gradually regressed.<xref rid="cit0021" ref-type="bibr">21</xref>
<italic toggle="yes">T. gondii CPS</italic> strains are not specific to melanoma, they show similar inhibitory effects on ovarian,<xref rid="cit0062" ref-type="bibr">62</xref> pancreatic,<xref rid="cit0063" ref-type="bibr">63</xref> and breast cancers.<xref rid="cit0064" ref-type="bibr">64</xref> Immune cells such as CD8<sup>+</sup> T cells and NK cells and immune-related substances such as IL-12, IFN-&#947;, and chemokine receptor 3 (CCR3) play key roles in this anti-tumor effect. Subsequently, the anti-tumor effect of <italic toggle="yes">T. gondii CPS</italic> strains was shown to be based on the secretion of rhoptry protein (ROP) or dense granule protein (GRA), and knockout of genes related to these two proteins resulted in a significant reduction of the anti-tumor effect.<xref rid="cit0024" ref-type="bibr">24</xref> Researchers also observed similar effects on the products of treated <italic toggle="yes">T. gondii</italic> as well. Back in the 1990s, researchers discovered the anti-tumor effect of <italic toggle="yes">T. gondii</italic> lysate antigen (TLA). After using <italic toggle="yes">T. gondii</italic> lysate antigen on YAC-1 lymphoma cell-loaded mice, a significant enhancement of the cytotoxic response was observed.<xref rid="cit0065" ref-type="bibr">65</xref> Treating mice with TLA before tumor emergence can delay tumor initiation. Based on histopathological observations, the TLA-treated group showed significant tumor necrosis and infiltration of lymphocytes and neutrophils compared with groups without TLA treatment.<xref rid="cit0066" ref-type="bibr">66</xref> Later, researchers found that TLA had an inhibitory effect on mouse colon cancer CT26 cells. After treating mice with TLA, they observed a significant reduction in the expression of the serum metastasis marker TIMP-1 and enhanced serum IL-12 and MyD88 signaling pathway expression in mouse macrophages.<xref rid="cit0067" ref-type="bibr">67</xref> Many experiments have shown that the TLA-induced maturation of dendritic cells exerts anti-tumor effects through specific immune functions.<xref rid="cit0068" ref-type="bibr">68</xref>,<xref rid="cit0069" ref-type="bibr">69</xref>
<italic toggle="yes">T. gondii</italic> virulence-associated dense granule protein (ToxoGRA15II) can induce host macrophage polarization to the M1 type and downregulation of matrix metalloproteinase-9 (MMP-9) and MMP-2, which in turn inhibits Hepa1-6 tumor cell metastasis and invasion.<xref rid="cit0070" ref-type="bibr">70</xref> ToxoGRA15II also induces polarized M1 cells to produce large amounts of TNF-&#945;, which can inhibit liver fibrosis and sarcoidosis.<xref rid="cit0071" ref-type="bibr">71</xref> In addition, since ToxoGRA15II is nontoxic to mammals, its potential value as a novel tool to modulate host immunity and anti-tumor is noteworthy. These studies have documented the immunomodulatory and anti-tumor effects of <italic toggle="yes">T. gondii</italic> through both cellular and animal experiments. In summary, <italic toggle="yes">T. gondii</italic> can transform tumors from &#8220;cold&#8221; to &#8220;hot&#8221; by awakening the host&#8217;s immune response and destroying the immunosuppressive tumor microenvironment, ultimately reducing the tumor size and inhibiting tumor metastasis. However, because of various obstacles such as biosafety issues and economic burdens, the clinical application of <italic toggle="yes">T. gondii</italic> requires more research support.
<fig position="float" id="f0002" fig-type="figure" orientation="portrait"><label>Figure 2</label><caption><p><italic toggle="yes">Toxoplasma gondii</italic> and tumor immunotherapy. <italic toggle="yes">T. gondii</italic> triggers a vigorous immune response in the host. Such vigorous immune responses can inhibit the progression of tumors. Research has found after infecting host immune cells, <italic toggle="yes">(T) gondii</italic> induces the production of certain soluble factors in host immune cells, which induce a strong and systematic suppression of tumor angiogenesis, leading to severe hypoxia within the tumor tissue. Furthermore, after <italic toggle="yes">T. gondii</italic> infection, substances from <italic toggle="yes">T. gondii</italic> such as ToxoGRA15II can activate the proliferation of NK cells, CD4<sup>+</sup> T cells, and CD8<sup>+</sup> and CTL cells, followed by inducing them to produce large amounts of IL-12 and IFN-&#947;. The ToxoGRA15II also can induce host macrophages to polarize to the M1 type and induce polarized M1 cells to generate large amounts of TNF-&#945;. All of these mechanisms can inhibit tumor cells.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" content-type="print-only" position="float" orientation="portrait" xlink:href="IJN-19-12421-g0003.jpg"/></fig></p></sec></sec><sec id="s0003"><title>Immunomodulatory and Anti-Tumor Effects of T. gondii-Derived Exosomes</title><sec id="s0003-s2001"><title>T. gondii-Derived Exosomes</title><p>Exosomes were first isolated from tumor cell lines in the 1880s and were initially described as vesicles with 5&#8217;-nucleotidase activity.<xref rid="cit0072" ref-type="bibr">72</xref> Subsequent research has shown that exosomes are nanoscale vesicles containing various components, such as proteins, nucleic acids, lipids, and metabolites, with diameters ranging from 30 nm to 150 nm; these vesicles are released from intracellular multivesicular bodies (MVBs).<xref rid="cit0073" ref-type="bibr">73</xref> Exosomes are produced by various cells and are involved in a wide range of physiological activities, such as cell-to-cell communication and functional regulation.<xref rid="cit0028" ref-type="bibr">28</xref> Exosomes play an important role in the generation, diagnosis, and treatment of tumors, infectious diseases, and cardiovascular diseases.<xref rid="cit0074" ref-type="bibr">74</xref>,<xref rid="cit0075" ref-type="bibr">75</xref> Recent studies have reported that numerous parasites, such as <italic toggle="yes">Schistosoma japonicum</italic>,<xref rid="cit0076" ref-type="bibr">76</xref>
<italic toggle="yes">Leishmania protozoa</italic>,<xref rid="cit0077" ref-type="bibr">77</xref>
<italic toggle="yes">Trypanosoma brucei</italic>,<xref rid="cit0078" ref-type="bibr">78</xref>
<italic toggle="yes">Plasmodium falciparum, Neospora caninum</italic>,<xref rid="cit0079" ref-type="bibr">79</xref> and many others, can communicate with host cells by secreting exosomes and delivering virulence factors, drug resistance factors, and differentiation factors, thus modulating the immune responses of hosts.<xref rid="cit0080" ref-type="bibr">80</xref>,<xref rid="cit0081" ref-type="bibr">81</xref>
<italic toggle="yes">T. gondii</italic> can also produce exosomes. Some researchers have successfully identified <italic toggle="yes">T. gondii</italic>-derived exosomes and analyzed them using proteomics, revealing several classical exosomal proteins.<xref rid="cit0082" ref-type="bibr">82</xref> Further studies on <italic toggle="yes">T. gondii</italic>-derived exosomes using transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA) revealed that <italic toggle="yes">T. gondii</italic>-derived exosomes range from 10 to 150 nm in diameter, averaging approximately 50 nm. The specific markers of <italic toggle="yes">T. gondii</italic>-derived exosomes, recombinant lysosomal associated membrane protein 3 (CD63), heat shock protein 70 (Hsp70), and surface antigen 1 (SAG1, also named P30), were also detected using protein blotting.<xref rid="cit0083" ref-type="bibr">83</xref></p></sec><sec id="s0003-s2002"><title>Isolation and Identification of T. gondii-Derived Exosomes</title><p>Exploring exosomes is highly important for related life science research. The prerequisites for exploring exosomes are isolation and characterization techniques with high purity and yield. Exosomes derived from different sources carry distinct bioactive substances,<xref rid="cit0028" ref-type="bibr">28</xref>,<xref rid="cit0084" ref-type="bibr">84</xref> and differ in size; thus, different isolation techniques are required.<xref rid="cit0085" ref-type="bibr">85</xref> Traditional isolation techniques include ultracentrifugation-based methods,<xref rid="cit0086" ref-type="bibr">86</xref>,<xref rid="cit0087" ref-type="bibr">87</xref> size-based methods<xref rid="cit0074" ref-type="bibr">74</xref> and precipitation,<xref rid="cit0088" ref-type="bibr">88</xref> as well as immunoaffinity capture, which is based on the binding of aptamers or antibodies to specific proteins in exosomes.<xref rid="cit0089" ref-type="bibr">89</xref> Currently, ultracentrifugation, which has the advantages of simplicity and quantity, is the gold standard for isolating exosomes and is suitable for large samples. However, some studies have shown that ultracentrifugation may destroy exosome vesicles and interfere with subsequent research.<xref rid="cit0090" ref-type="bibr">90</xref> In summary, traditional exosome isolation techniques are cumbersome, require special equipment, and are costly and time-consuming. Researchers often combine these techniques in complementary manners, for example, by combining ultrafiltration with size-exclusion chromatography (SEC), which allows for the extraction of higher-purity free exosome concentrates.<xref rid="cit0091" ref-type="bibr">91</xref>,<xref rid="cit0092" ref-type="bibr">92</xref> In recent years, novel technologies have emerged, providing new possibilities for exosome isolation and characterization. Microfluidic chip technology is based on a chip containing numerous microtubules that can handle microvolume fluid.<xref rid="cit0093" ref-type="bibr">93</xref> In the field of exosome isolation and identification, synthesized microfluidic chip systems combining ultracentrifugation, immunoaffinity capture methods, and other technologies have emerged.<xref rid="cit0094" ref-type="bibr">94</xref>,<xref rid="cit0095" ref-type="bibr">95</xref> These methods are convenient, automated, and applicable for the analysis of minor samples due to their low throughput. Some researchers have achieved markerless detection of PD-L1 in exosomes using surface plasmon resonance (SPR) biochips.<xref rid="cit0096" ref-type="bibr">96</xref> Proper culture of <italic toggle="yes">T. gondii</italic> and obtaining supernatants that contain <italic toggle="yes">T. gondii</italic>-derived exosomes is essential for their isolation. Two common techniques determine the purity and yield of <italic toggle="yes">T. gondii</italic>-derived exosomes.<xref rid="cit0082" ref-type="bibr">82</xref>,<xref rid="cit0097" ref-type="bibr">97</xref> First, the host cells are infected with <italic toggle="yes">T. gondii</italic> tachyzoites. After a period of coculture, <italic toggle="yes">T. gondii</italic> is separated from the cells by centrifugation. Then, activated <italic toggle="yes">T. gondii</italic> is introduced into medium without exosomes, and the supernatant is collected for subsequent isolation after the appropriate time. Second, based on the former method, without separating activated <italic toggle="yes">T. gondii</italic> from the host cells, the culture is continued, and the supernatant containing exosomes is collected for subsequent isolation (<xref rid="f0003" ref-type="fig">Figure 3</xref>). The latter technique enables specialized intracellular parasitism of <italic toggle="yes">T. gondii</italic> and can maintain <italic toggle="yes">T. gondii</italic> activity for a long time, resulting in a greater yield of exosomes. However, this approach results in lower purity because host cells can also secrete exosomes. For the isolation of <italic toggle="yes">T. gondii</italic>-derived exosomes from the supernatant, the most used methods include centrifugation and exosome sorting kits. Exosome sorting kits are based on polymer precipitation technology and allow easier handling, lack special equipment, as well as higher recovery rates than centrifugation.<xref rid="cit0098" ref-type="bibr">98</xref> After repeated centrifugation and concentration of the supernatants of <italic toggle="yes">T. gondii</italic> cocultured with cells in combination with specialized kits, exosome samples meeting the requirements for subsequent experiments can be extracted. However, problems such as lower purity due to nonexosome contamination still cannot be solved. The use of emerging technologies such as microfluidic microarrays with high purity and high recovery rates for the isolation and characterization of <italic toggle="yes">T. gondii</italic>-derived exosomes is a new direction for future research. After extracting <italic toggle="yes">T. gondii</italic>-derived exosomes, the concentration, ultrastructure, particle size, and markers of exosomes must be determined using techniques such as nanoparticle tracking and analysis (NTA), TEM, scanning electron microscopy (SEM) and Western blotting (WB) for subsequent analysis.<xref rid="cit0099" ref-type="bibr">99</xref>,<xref rid="cit0100" ref-type="bibr">100</xref>
<fig position="float" id="f0003" fig-type="figure" orientation="portrait"><label>Figure 3</label><caption><p>Isolation and composition of <italic toggle="yes">T. gondii</italic>-derived exosomes. Depending on the required purity and yield of <italic toggle="yes">T. gondii</italic>-derived exosomes, two common <italic toggle="yes">T. gondii</italic> culture techniques are used (continuous coculture and individual culturing). The former continuously co-cultures <italic toggle="yes">T. gondii</italic> with host cells and collects supernatants. The latter cultures <italic toggle="yes">T. gondii</italic> alone. In addition to exosomes, the supernatants also contained a large number of ectosomes, cell debris, and apoptotic bodies. Such components need to be detached by appropriate isolation methods. After filtration and concentration, the supernatant can be used for isolation. The most used methods for the isolation of <italic toggle="yes">T. gondii</italic>-derived exosomes include centrifugation and exosome sorting kits. In recent years, microfluidics chip systems have provided new possibilities for exosome isolation and characterization. Upon characterization, the researchers found that T. gondii-derived exosomes&#160;contain various proteins&#160;(including Rab protein, Toll-like receptors, surface antigen, CD63, extracellular matrix glycoproteins, fiber-associated proteins, calcium-binding proteins, enzyme, microneme proteins, cytoskeletal proteins, heat shock proteins, granule protein, rhoptry protein, and ToxoGRA15II),&#160;lipids (including phosphatidic acid, cholesterol, and sphingomyelin), and nucleic acids (including RNA, DNA, and non-coding RNA).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" content-type="print-only" position="float" orientation="portrait" xlink:href="IJN-19-12421-g0004.jpg"/></fig></p></sec><sec id="s0003-s2003"><title>Composition of T. gondii-Derived Exosomes</title><p>The immunomodulatory functions of <italic toggle="yes">T. gondii</italic>-derived exosomes rely on their contents of proteins, nucleic acids, and lipids. Omics analysis of <italic toggle="yes">T. gondii</italic>-derived exosomes will contribute to unraveling their biological functions. <italic toggle="yes">T. gondii</italic>-derived exosomes contain various protein components, including ROP proteins, GRA proteins, microneme proteins (MIC), surface antigen (SAG), cytoskeletal proteins, heat shock proteins (HSP), and Rab proteins.<xref rid="cit0037" ref-type="bibr">37</xref>,<xref rid="cit0082" ref-type="bibr">82</xref> These proteins widely participate in several physiological processes, such as invading host cells and regulating host immunity. Some researchers analyzed proteins of exosomes derived from <italic toggle="yes">T. gondii, T. gondii</italic>-infected human foreskin fibroblasts (HFFs), and <italic toggle="yes">T. gondii</italic>-uninfected HFFs utilizing NTA, qubit fluorometric quantification, and other proteomics-related techniques.<xref rid="cit0082" ref-type="bibr">82</xref> Notably, 346, 69, and 15 proteins were successfully identified as specific to exosomes from the three sources, respectively, and 216 proteins were common. A comparison of the 216 common proteins with the EVpedia database revealed that 24.7% of proteins are among the top 100 proteins in the EVpedia database,<xref rid="cit0101" ref-type="bibr">101</xref> including classical exosome protein markers such as extracellular matrix glycoproteins, calcium-binding proteins, fiber-associated proteins, membrane-bound protein family members, HSP70, and CD63. Later, another researcher successfully identified the protein composition of <italic toggle="yes">T. gondii</italic>-derived exosomes, which consisted of 3 MIC proteins, 11 GRA proteins, 16 ROP proteins, 12 SAG proteins, 3&#160;hSP proteins, 5 Rab proteins, 10 kinases, 3 phosphatases, 7 proteases, and 215 other proteins (<xref rid="f0003" ref-type="fig">Figure 3</xref>).<xref rid="cit0102" ref-type="bibr">102</xref></p><p><italic toggle="yes">T. gondii</italic>-derived exosomes also contain abundant nucleic acid components (<xref rid="f0003" ref-type="fig">Figure 3</xref>), including miRNAs, but their types, quantities, and functions remain unclear.<xref rid="cit0037" ref-type="bibr">37</xref>,<xref rid="cit0103" ref-type="bibr">103</xref> Current research focuses on exosomes derived from host immune cells infected with <italic toggle="yes">T. gondii. T. gondii</italic> stimulates host dendritic cells to produce exosomes, which contain various mRNAs and miRNAs. After exosomes are internalized by recipient cells, these RNAs further influence biological processes such as immune responses in the organism by regulating gene expression. Several researchers have extracted and purified exosomal RNA from <italic toggle="yes">T. gondii</italic> (PRU strain) tachyzoites that infected HFFs using ultracentrifugation and an exosome sorting kit and analyzed it with microarrays. A total of 222 differentially expressed RNAs were found, and miR-23b was highly expressed. miR-23b can regulate the immune response in host cells by inhibiting the expression of the cytokine IL-17.<xref rid="cit0104" ref-type="bibr">104</xref> Some researchers have observed that exosomes derived from rat myoblast L6 cells infected with <italic toggle="yes">T. gondii</italic> (RH strain) tachyzoites contain 64 differentially expressed miRNAs. Eleven of these miRNAs are related to the cell cycle and proliferation and regulate various cell cycle-related genes, such as cytochalasin D2.<xref rid="cit0105" ref-type="bibr">105</xref> In recent years, another researcher performed a high-throughput analysis of exosomes derived from DC cells infected with tachyzoites of <italic toggle="yes">T. gondii</italic> (RH strain) and found 3434 more miRNAs than exosomes from DC cells not infected with <italic toggle="yes">T. gondii</italic>. Further bioinformatics analyses revealed that 12 of these stably enriched miRNAs were extensively involved in host innate immune regulatory processes.<xref rid="cit0026" ref-type="bibr">26</xref></p><p>Studies on the lipid composition of exosomes are limited. According to the ExoCarta database, exosome membranes contain 1116 lipids, including cholesterol, sphingomyelin, and phosphatidic acid (PA), in varying quantities.<xref rid="cit0106" ref-type="bibr">106</xref> The total amounts and components of exosomal lipids vary among different subtypes and are closely related to their original cells.<xref rid="cit0107" ref-type="bibr">107</xref> A study revealed that exosomes from sheep erythrocyte culture supernatants contained high levels of sphingomyelin, which is specific to the plasma membranes of sheep erythrocytes.<xref rid="cit0108" ref-type="bibr">108</xref> Exosomes secreted by B cells contain lipid components such as lysophosphatidic acid (LPA) and cholesterol (<xref rid="f0003" ref-type="fig">Figure 3</xref>).<xref rid="cit0109" ref-type="bibr">109</xref>,<xref rid="cit0110" ref-type="bibr">110</xref> Studies on the lipid composition of <italic toggle="yes">T. gondii</italic>-derived exosomes are lacking, but researchers have hypothesized that <italic toggle="yes">T. gondii</italic>-derived exosomes contain specific lipid fractions from <italic toggle="yes">T. gondii</italic>. However, related issues remain to be explored.</p><p>During the invasion of host cells by <italic toggle="yes">T. gondii</italic>, the various components mentioned above are loaded into exosomes and then involved in host cell adhesion, invasion, and intracellular localization. Examples include proteins such as MIC2 and MIC4, which are involved in the adhesion process;<xref rid="cit0111" ref-type="bibr">111</xref>,<xref rid="cit0112" ref-type="bibr">112</xref> ROP and GRA proteins, which collectively participate in the formation of intracellular parasitophorous vacuoles;<xref rid="cit0113" ref-type="bibr">113</xref> and RON proteins and AMA1 proteins, which form kinetic linkages during <italic toggle="yes">T. gondii</italic> exosome internalization and serve to exclude host plasma membranes.<xref rid="cit0114" ref-type="bibr">114</xref></p></sec><sec id="s0003-s2004"><title>Immunomodulatory Activity of T. gondii-Derived Exosomes</title><p>A few studies have investigated the immunomodulatory function of <italic toggle="yes">T. gondii</italic>-derived exosomes. Some researchers successfully isolated and identified <italic toggle="yes">T. gondii</italic>-derived exosomes using TEM, NTA, and WB techniques and cocultured high concentrations of <italic toggle="yes">T. gondii</italic>-derived exosomes with a mouse macrophage line (RAW264.7). Finally, the extraction and analysis of the supernatants revealed that macrophages secreted significantly more IL-12, TNF-&#945;, and IFN-&#947; but secreted significantly less IL-10. Researchers also immunized BALB/c mice with <italic toggle="yes">T. gondii</italic> RH strain tachyzoite exosomes (Exo-R) and <italic toggle="yes">T. gondii</italic> Me49 strain tachyzoite exosomes (Exo-M). High levels of IgG2&#945; were detected in serum from both groups of mice, and the levels of IgG2&#945; were significantly higher than those of IgG1, suggesting that <italic toggle="yes">T. gondii</italic>-derived exosomes induced the onset of a Th1-type cellular immune response in mice. Moreover, the percentages of CD8<sup>+</sup> T cells in the spleens of exosome-treated mice and the concentrations of IFN-&#947; and IL-12 in the supernatants of splenic lymphocyte cultures were significantly higher than those in the controls, which supports the view that <italic toggle="yes">T. gondii</italic>-derived exosomes stimulate humoral and cellular immunity in mice (<xref rid="f0004" ref-type="fig">Figure 4</xref>).<xref rid="cit0083" ref-type="bibr">83</xref> Subsequent experiments on the function of <italic toggle="yes">T. gondii</italic>-derived exosomes in macrophages using similar methods revealed a significant increase in the concentrations of IL-12, IFN-&#947;, and TNF-&#945; secreted by macrophages under the effect of <italic toggle="yes">T. gondii</italic>-derived exosomes, which was shown to be the result of exosomes triggering innate immunity by activating the c-Jun N-terminal kinase (JNK) signaling pathway.<xref rid="cit0097" ref-type="bibr">97</xref> In recent years, some researchers have also immunized mice with purified <italic toggle="yes">T. gondii</italic>-derived exosomes and found that IFN-&#947; and TNF-&#945; levels were significantly increased in brain and spleen cells, and the mortality rate of <italic toggle="yes">T. gondii</italic>-infected mice was also significantly decreased.<xref rid="cit0115" ref-type="bibr">115</xref> Another study revealed that <italic toggle="yes">T. gondii</italic> secretes exosomes after host invasion, and the exosomes present <italic toggle="yes">T. gondii</italic> antigens to T cells either directly or via antigen-presenting cells, which activate T cells and immune responses.<xref rid="cit0039" ref-type="bibr">39</xref>
<fig position="float" id="f0004" fig-type="figure" orientation="portrait"><label>Figure 4</label><caption><p>Immunomodulatory effect of <italic toggle="yes">T. gondii</italic>-derived exosomes. Both cellular and animal experiments revealed that high concentrations of <italic toggle="yes">T. gondii</italic>-derived exosomes stimulated increased secretion of IL-12, TNF-&#945;, and IFN-&#947; from immune cells. Coculture of <italic toggle="yes">T. gondii</italic>-derived exosomes with RAW264.7 and an analysis of the final extracted supernatant revealed a significant increase in the secretion of IL-12, TNF-&#945;, and IFN-&#947; from RAW264.7. The percentage of CD8<sup>+</sup> T cells and the concentrations of IFN-&#947; and IL-12 produced by CD8<sup>+</sup> T cells were significantly higher in the spleen cells of mice treated with exosomes.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" content-type="print-only" position="float" orientation="portrait" xlink:href="IJN-19-12421-g0005.jpg"/></fig></p></sec><sec id="s0003-s2005"><title>Immunomodulatory Effect of T. gondii-Infected Cell-Derived Exosomes</title><p>Other studies on the immunomodulatory effect of <italic toggle="yes">T. gondii</italic>-associated exosomes have focused on exosomes derived from infected host cells.<xref rid="cit0060" ref-type="bibr">60</xref>,<xref rid="cit0116" ref-type="bibr">116</xref> After invading the host, <italic toggle="yes">T. gondii</italic> can stimulate the production of exosomes by dendritic cells, macrophages, monocytes, and even tumor cells. In 2004, researchers stimulated host dendritic cells to produce exosomes using soluble <italic toggle="yes">T. gondii</italic> antigens and attempted to prepare cell-free vaccines based on exosomes. After injecting exosomes into mice, a significant increase in IL-2 and IFN-&#947; levels in mouse splenocytes was observed, suggesting the generation of vigorous Th1-type cellular immune responses and a favorable anti-infective effect.<xref rid="cit0117" ref-type="bibr">117</xref> After phagocytosis of <italic toggle="yes">T. gondii</italic>, macrophages can release exosomes with <italic toggle="yes">T. gondii</italic> antigens, and these exosomes activate other macrophages to release cytokines, such as TNF-&#945;, and destroy pathogens.<xref rid="cit0118" ref-type="bibr">118</xref> The <italic toggle="yes">T. gondii</italic>-infected human monocyte cell line THP-1 also releases exosomes that stimulate uninfected THP-1 cells to produce TNF-&#945; and other proinflammatory mediators to protect against infection.<xref rid="cit0118" ref-type="bibr">118</xref> Exosomes derived from infected dendritic cells of pregnant maternal mice protect murine fetuses from vertically transmitted infections, and cystic loads in the brains of pups were found to be significantly reduced. This effect was accompanied by strong immune responses and changes in the expression levels of numerous cytokines in the serum of mice.<xref rid="cit0119" ref-type="bibr">119</xref> In recent years, several studies have attempted to validate the therapeutic effect of exosomes secreted by dendritic cells infected with the <italic toggle="yes">T. gondii</italic> Me49 strain (Me49-DC-Exos) in mouse colorectal cancer models. Significant inhibition of tumor growth was observed, and subsequent experiments verified that Me49-DC-Exos achieved tumor inhibition by regulating the proportion of myeloid-derived suppressor cells through the suppression of signal transducer activator of transcription 3 (STAT3).<xref rid="cit0116" ref-type="bibr">116</xref> Researchers followed up with experiments comparing the effects of uninfected dendritic cell exosomes (DC-Exos) with those of Me49-DC-Exos in colon cancer-bearing mice. Tumor growth was significantly inhibited in the Me49-DC-Exo group compared to the DC-Exo group, and the proportion of M2 macrophages in mouse blood decreased markedly. In subsequent cellular experiments, this outcome resulted from exosomes regulating SOCS1 gene expression, and an increase in SOCS1 gene expression increased the proportion of M1 macrophages.<xref rid="cit0060" ref-type="bibr">60</xref> Recently, several researchers have extracted exosomes from <italic toggle="yes">T. gondii</italic>-infected human hepatoblastoma cells, treated them with alum adjuvant, and performed immune induction experiments on cerebral cyst-loaded mice. The expression of IFN-&#947; and IL-4 and the numbers of CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes were significantly elevated in mice, suggesting the successful induction of humoral immunity and mixed Th 1/Th 2 cell immunity and a marked reduction in the brain cyst load by 75% in mice.<xref rid="cit0120" ref-type="bibr">120</xref> These findings provide new insights into tumor immunotherapy. The ability of <italic toggle="yes">T. gondii</italic>-derived exosomes to modulate host immune responses confers their potential as tumor immunotherapy vaccines (<xref rid="f0005" ref-type="fig">Figure 5</xref>). In addition, <italic toggle="yes">T. gondii</italic>-derived exosomes may also affect the host cell cycle and proliferation. Researchers have found that L6 cells infected with <italic toggle="yes">T. gondii</italic> RH strains have a decreased proliferative capacity and an increased proportion of cells in S phase or G2/M phase.<xref rid="cit0105" ref-type="bibr">105</xref>
<fig position="float" id="f0005" fig-type="figure" orientation="portrait"><label>Figure 5</label><caption><p>Immunomodulatory effects of <italic toggle="yes">T. gondii</italic>-infected cell-derived exosomes. After invading the host, <italic toggle="yes">(T) gondii</italic> stimulates dendritic cells, monocytes, macrophages, and even tumor cells to produce exosomes. After injecting the acellular vaccine made from exosomes produced by dendritic cells into mice, a significant increase in cytokine levels in splenocytes is observed. <italic toggle="yes">T. gondii</italic>-infected human monocyte cell line THP-1 also releases exosomes that stimulate uninfected THP-1 monocytes to secrete TNF-&#945; and other proinflammatory mediators. Macrophages phagocytose <italic toggle="yes">T. gondii</italic> and release exosomes containing <italic toggle="yes">T. gondii</italic> antigens, which stimulate other macrophages to polarise toward the M1 type and secrete cytokines. Exosomes extracted from <italic toggle="yes">T. gondii</italic>-infected tumor cells, alum processed, and subjected to immune induction experiments in mice with brain cysts also showed a significant increase in cytokine expression.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" content-type="print-only" position="float" orientation="portrait" xlink:href="IJN-19-12421-g0006.jpg"/></fig></p></sec><sec id="s0003-s2006"><title>Potential of T. gondii-Derived Exosomes in Tumor Immunotherapy</title><p>Although few relevant studies are available, the potential of <italic toggle="yes">T. gondii</italic>-derived exosomes in tumor immunotherapy remains noteworthy. First, numerous studies have reported the role of <italic toggle="yes">T. gondii</italic> in immune modulation and tumor therapy. As mentioned above, direct use of attenuated <italic toggle="yes">T. gondii</italic> strains or <italic toggle="yes">T. gondii</italic> extracts such as TLA, GRA, and ROP can stimulate host immune cells, including dendritic cells, macrophages, CD8<sup>+</sup> T cells, and NK cells, and induce significantly increased expression of cytokines and other factors, such as IL-12, IFN-&#947;, and TNF-&#945;; such strong immune responses can simultaneously inhibit tumor progression.<xref rid="cit0024" ref-type="bibr">24</xref>,<xref rid="cit0067" ref-type="bibr">67</xref> Essentially, this effect stems from <italic toggle="yes">T. gondii</italic>&#8217;s Profilin-like proteins, ToxoGRA15II, RNA, and other immunogenic contents.<xref rid="cit0048" ref-type="bibr">48</xref>,<xref rid="cit0070" ref-type="bibr">70</xref> These components, when recognized by host immune cells, activate a series of immune responses, such as subsequent antigen processing and antigen presentation, which in turn play an anti-tumor role. The composition and function of exosomes are closely related to their original cells. During the formation of exosomes, associated molecules in the cytoplasm, such as nucleic acids, lipids, and proteins, are endocytosed and transferred to early endosomes. Early endosomes mature and differentiate into late MVBs or endosomes, which are degraded after binding with lysosomes or fusing with plasma membranes and are subsequently released to extracellular sites to form exosomes.<xref rid="cit0121" ref-type="bibr">121</xref>,<xref rid="cit0122" ref-type="bibr">122</xref> In summary, exosomes contain specific substances, such as proteins from the cells of origin, which could provide <italic toggle="yes">T. gondii</italic>-derived exosomes with immunomodulatory and anti-tumor effects similar to those of living <italic toggle="yes">T. gondii</italic> strains.</p><p>As an anti-tumor tool, <italic toggle="yes">T. gondii</italic>-derived exosomes possess numerous advantages over live <italic toggle="yes">T. gondii</italic> strains. For example, as exosome extraction and identification techniques continuously develop, obtaining high-precision and high-purity target exosomes becomes simpler.<xref rid="cit0123" ref-type="bibr">123</xref> Compared to live <italic toggle="yes">T. gondii</italic> strains, exosomes can be collected and preserved in large quantities upfront without longer-term live cell maintenance cultures to maintain their activity. In addition, <italic toggle="yes">T. gondii</italic>-derived exosomes are significantly superior to live <italic toggle="yes">T. gondii</italic> strains in terms of biosafety. <italic toggle="yes">T. gondii</italic> contains other unidentified components, and even after attenuation, direct use in patients may still have unforeseen adverse effects. Exosomes are composed of phospholipid bilayers, which can be easily accessed by receptor cells through ligand&#8211;receptor binding or direct membrane fusion, endocytosis, and even phagocytosis.<xref rid="cit0124" ref-type="bibr">124</xref>,<xref rid="cit0125" ref-type="bibr">125</xref> They can also cross biological barriers such as the BBB, intestinal barrier, and placental barrier to reach specific sites and therefore could be used in various drug delivery routes.<xref rid="cit0126" ref-type="bibr">126</xref> Exosomes, as natural carriers of intercellular information, possess high stability, low toxicity, and low immunogenicity in the circulation, as well as excellent modifiability; thus, they can be used for the loading and transportation of therapeutic drugs as novel drug delivery platforms and have high potential as immunomodulatory and anti-tumor agents.<xref rid="cit0127" ref-type="bibr">127</xref>,<xref rid="cit0128" ref-type="bibr">128</xref> In summary, the significant potential of <italic toggle="yes">T. gondii</italic>-derived exosomes in the field of tumor immunotherapy merits attention.</p></sec></sec><sec id="s0004"><title>Prospects of T. gondii-Derived Exosomes in Tumor Therapy</title><p>Immunotherapy or chemotherapy drugs need to be delivered precisely to target cells to achieve therapeutic efficacy and avoid the adverse effects associated with whole-body drug administration. However, deep tumors remain difficult to treat pharmacologically due to the presence of biological barriers such as the BBB. In addition, the nutritional blood vessels of tumors are mostly distributed more densely around the periphery of tumors, making it difficult to transport drugs through the circulation to the center of tumors, which affects drug efficacy.<xref rid="cit0129" ref-type="bibr">129</xref> Some researchers have found that some chemotherapy drugs are poorly targeted when conducting tumor chemotherapy, leading to decreased anti-tumor effects and an increased incidence of various adverse reactions, such as neurotoxicity<xref rid="cit0130" ref-type="bibr">130</xref> and cardiovascular toxicity.<xref rid="cit0131" ref-type="bibr">131</xref> Research on drug delivery systems (DDSs) to improve drug efficacy is emerging. DDSs are designed to efficiently deliver drug molecules to targets and reduce the incidence of adverse reactions. Popularly utilized DDSs include nanomaterials, liposomes,<xref rid="cit0132" ref-type="bibr">132</xref> and hydrogels.<xref rid="cit0133" ref-type="bibr">133</xref></p><p>In recent years, studies have consistently documented the potential of engineered exosomes with appropriate modifications as drug carriers in various oncology therapies.<xref rid="cit0127" ref-type="bibr">127</xref>,<xref rid="cit0134" ref-type="bibr">134</xref> Engineered exosomes, as novel drug carriers for tumor therapy, offer long half-lives, better biocompatibility, low toxicity, greater tissue targeting ability, and high modifiability compared to current well-established DDSs, such as liposomes and polymer nanoparticles,<xref rid="cit0135" ref-type="bibr">135</xref>,<xref rid="cit0136" ref-type="bibr">136</xref> and have relatively fewer adverse effects.<xref rid="cit0137" ref-type="bibr">137</xref> The introduction of anti-tumor drugs into exosomes by electroporation and other techniques to obtain nanoplatforms, the so-called Trojan horse, which can cross biological barriers and penetrate deeply into tumor tissues, dramatically improves the therapeutic effect of these drugs.<xref rid="cit0138" ref-type="bibr">138</xref> Biomodification of exosomes is also possible using targeting peptides<xref rid="cit0139" ref-type="bibr">139</xref> or aptamers,<xref rid="cit0140" ref-type="bibr">140</xref> which can endow exosomes with significantly higher tumor affinity and specific targeting capabilities, further enhancing their efficacy and preventing adverse reactions. Accordingly, researchers have developed exosomes expressing characteristic exosomal membrane proteins and loaded them with drugs such as doxorubicin (Dox) by electroporation. In experiments in which tumor-loaded mice were treated, these exosomes exhibited significant tumor growth inhibition without remarkable toxicity.<xref rid="cit0141" ref-type="bibr">141</xref>,<xref rid="cit0142" ref-type="bibr">142</xref></p><p><italic toggle="yes">T. gondii</italic>-derived exosomes possess multiple advantages from exosomes, as they inherit the characteristics, components, and ability of <italic toggle="yes">T. gondii</italic> to modulate the host immune response, which can overcome various shortcomings of existing DDSs and has promising applications in tumor therapy (<xref rid="f0006" ref-type="fig">Figure 6</xref>). <italic toggle="yes">T. gondii</italic>-derived exosomes can activate host antigen presentation, stimulate host immune cell secretion, weaken the immunosuppressive microenvironment, and greatly increase the expression of cytokines such as IL-12, TNF-&#945;, and IFN-&#947;. When applied for tumor immunotherapy, engineered <italic toggle="yes">T. gondii</italic>-derived exosomes can accurately and efficiently deliver drugs such as PD-1 monoclonal antibody, Dox, and RNA to target cells. In addition, these exosomes weaken the immunosuppressive microenvironment induced by tumor cells, restore the anti-tumor effects of T cells and other immune cells, and transform tumors from &#8220;cold&#8221;&#160;to &#8220;hot&#8221;, resulting in efficient anti-tumor effects on deep tumors. However, there are still challenges that need to be overcome on the path to clinical translation of <italic toggle="yes">T. gondii</italic>-derived exosomes. Firstly, both existing <italic toggle="yes">T. gondii</italic> culture techniques are flawed (<xref rid="f0003" ref-type="fig">Figure 3</xref>). Co-culture with host cells results in exosomes from host cells being mixed in the collected supernatant. Individual culturing of <italic toggle="yes">T. gondii</italic> reduces the activity of <italic toggle="yes">T. gondii</italic>, leading to a reduction in the quality and quantity of exosomes secreted by <italic toggle="yes">T. gondii</italic>. Secondly, <italic toggle="yes">T. gondii</italic> can be divided into various subtypes; therefore, it is necessary to investigate the distinct host immunomodulatory functions of exosomes from different subtypes of <italic toggle="yes">T. gondii</italic> for the sake of safer clinical application. In addition, because <italic toggle="yes">T. gondii</italic>-derived exosomes contain a variety of antigenic components from <italic toggle="yes">T. gondii</italic>, they acquire the ability to modulate host immunity while inevitably potentially causing adverse reactions in the host. Therefore, more research is necessary to investigate the specific <italic toggle="yes">T. gondii</italic> antigenic components in <italic toggle="yes">T. gondii</italic>-derived exosomes and their mechanisms of host immunomodulatory effects. Pursuing the goal of achieving precise sorting of <italic toggle="yes">T. gondii</italic>-derived exosomes, and even attenuating or removing specific antigenic components. In addition, with further research on <italic toggle="yes">T. gondii</italic>-derived exosomes and advances in related production technologies, the use of laboratory-produced DDSs containing <italic toggle="yes">T. gondii</italic> components may be able to activate the host immune response while offering a better biosafety profile. Finally, because therapy with <italic toggle="yes">T. gondii</italic>-derived exosomes relies on an intact immune system, it may be significantly less effective when used in tumor patients with severe immunocompromise. To date, research on the application of <italic toggle="yes">T. gondii</italic>-derived exosomes remains in the exploratory stage. <italic toggle="yes">T. gondii</italic>-derived exosomes may become an excellent tool for tumor therapy in the future.
<fig position="float" id="f0006" fig-type="figure" orientation="portrait"><label>Figure 6</label><caption><p>Prospects of <italic toggle="yes">T. gondii</italic>-derived exosomes in tumor therapy. Immunotherapeutic or chemotherapeutic drugs need to be delivered precisely to the target tissues to achieve therapeutic efficacy and avoid the adverse effects associated with systemic drug administration. Biomodification of <italic toggle="yes">T. gondii</italic>-derived exosomes using targeting peptides or aptamers can endow <italic toggle="yes">T. gondii</italic>-derived exosomes with significantly higher tumor affinity and specific targeting capabilities. These engineered <italic toggle="yes">T. gondii</italic>-derived exosomes can be loaded with doxorubicin, PD-1 monoclonal antibody, and RNA to cross biological barriers such as the blood-brain barrier to reach deep-seated tumors and can also proactively activate host immune cells to increase the expression of cytokines such as IL-12, INF-&#947;, and TNF-&#945;, or directly deliver loaded drugs to the tumor cells to achieve anti-tumor effects.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" content-type="print-only" position="float" orientation="portrait" xlink:href="IJN-19-12421-g0007.jpg"/></fig></p></sec><sec id="s0005"><title>Conclusion</title><p>The emergence of tumor immunotherapy has brought a new pathway for tumor treatment but also confronts obstacles such as low response rates and adverse effects. The ability of <italic toggle="yes">T. gondii</italic> to modulate host immunity and combat tumors has been demonstrated in some studies, making it a possible tool for adjuvant tumor immunotherapy. However, <italic toggle="yes">T. gondii</italic> cultures are technically sensitive and suffer from biosafety concerns, limiting the availability of applications in tumor immunotherapy. In order to address these problems, finding new ways to utilize <italic toggle="yes">T. gondii</italic> has become critical. Evidence provided herein suggests that <italic toggle="yes">T. gondii</italic> can also secrete exosomes and that they may be a potent tool to assist in tumor immunotherapy. Firstly, <italic toggle="yes">T. gondii</italic> exosomes are characterized by low toxicity and immunogenicity. Secondly, it can be collected in large quantities in advance without long-term live cell culture. Finally, <italic toggle="yes">T. gondii</italic> exosomes contain fewer unidentified components than live <italic toggle="yes">T. gondii</italic> strains, making their biosafety performance superior. Based on these, the modified engineered <italic toggle="yes">T. gondii</italic> exosomes platform has a longer half-life, better biocompatibility, and better targetability. Such platforms can load anti-tumor drugs (such as PD-1 monoclonal antibody, Dox, and RNA) across biological barriers (such as the BBB) to precisely reach the tumor sites. Meanwhile, it can also stimulate immune cells, increase the expression of various cytokines, relieve the tumor-induced immunosuppressive microenvironment, and ultimately enhance the anti-tumor efficacy. Further work is required to bring engineered <italic toggle="yes">T. gondii</italic> exosomes into clinical application. Firstly, researchers are needed to examine and minimize the cytotoxicity and immunogenicity of <italic toggle="yes">T. gondii</italic>-derived exosomes. Secondly, existing exosome isolation and extraction techniques have been applied most frequently to various cells and relatively few to <italic toggle="yes">T. gondii</italic>. Thus, to increase the purity and yield of the exosomes obtained from <italic toggle="yes">T. gondii</italic>, it is necessary to further test the ability of <italic toggle="yes">T. gondii</italic> to secrete exosomes, as well as to develop the isolation and extraction techniques suitable for <italic toggle="yes">T. gondii</italic>. Thirdly, more animal experiments should then be carried out to clarify the specific mechanism of the immunomodulatory function of engineered <italic toggle="yes">T. gondii</italic>-derived exosomes&#160;on organisms, to assess their anti-tumor and biosafety properties, and to study their stability within the blood circulation, pharmacokinetics, and pharmacodynamics. Finally, the criteria for approval for marketing can only be met after a series of rigorously designed clinical trials with the cooperation of clinicians. In conclusion, continued understanding, experimentation, and application of the immune response regulation mechanisms and potential as carriers of anti-tumor drugs of <italic toggle="yes">T. gondii</italic> exosomes can provide new perspectives in tumor immunotherapy.</p></sec></body><back><sec id="s0006"><title>Abbreviations</title><p>BBB, Blood&#8210;brain barrier; CCR3, Chemokine receptor 3; CAR-T, Chimeric antigen receptor T-cell; JNK C-Jun N-terminal kinase; CTL, Cytotoxic T lymphocyte; DC-Exos, Dendritic cell exosomes; GRA, Dense granule protein; Dox, Doxorubicin; DDSs, Drug delivery systems; Me49-DC-Exos, Exosomes secreted by dendritic cells infected with the <italic toggle="yes">T. gondii</italic> Me49 strain; HSP, Heat shock proteins; HFFs, Human foreskin fibroblasts; ICB, Immune checkpoint blockade; ILCs1, Innate lymphoid cells Group 1; IFN-&#947;, Interferon-&#947;; IL-12 Interleukin 12; LPA, Lysophosphatidic acid; MMP-9, Matrix metalloproteinase-9; MIC, Microneme proteins; MVBs, Multivesicular bodies; NTA, Nanoparticle tracking analysis; NK, Natural killer; PAMPs, Pathogen-associated molecular patterns; PA, Phosphatidic acid; CD63 Recombinant lysosomal associated membrane protein 3; ROP, Rhoptry protein; SEM, Scanning electron microscopy; SEC, Size-exclusion chromatography; SAG, Surface antigen; SAG1, Surface antigen 1 (also named P30); SPR, Surface plasmon resonance; TLA, <italic toggle="yes">T. gondii</italic> lysate antigen; Exo-M, <italic toggle="yes">T. gondii</italic> Me49 strain tachyzoite exosomes; <italic toggle="yes">CPS T. gondii</italic> nonreplicating avirulent uracil auxotroph vaccine strain; Exo-R <italic toggle="yes">T. gondii</italic> RH strain tachyzoite exosomes; ToxoGRA15II <italic toggle="yes">T. gondii</italic> virulence-associated dense granule protein; TLRs, Toll-like receptors; <italic toggle="yes">T. gondii, Toxoplasma gondii</italic>; STAT3, Transcription 3; TEM, Transmission electron microscopy; TNF-&#945;, Tumor necrosis factor-&#945;; UMP, Uridine-5&#8217;-mono-phosphate; WB, Western blotting.</p></sec><sec id="s0007"><title>Author Contributions</title><p>All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.</p></sec><sec sec-type="COI-statement" id="s0008"><title>Disclosure</title><p>The authors report no conflicts of interest in this work.</p></sec><ref-list><title>References</title><ref id="cit0001"><label>1.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Sung</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Ferlay</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Siegel</surname><given-names>RL</given-names></string-name>, et al. <article-title>Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries</article-title>. <source><italic toggle="yes">CA Cancer J Clin</italic></source>. <year>2021</year>;<volume>71</volume>(<issue>3</issue>):<fpage>209</fpage>&#8211;<lpage>249</lpage>. doi:<pub-id pub-id-type="doi">10.3322/caac.21660</pub-id><pub-id pub-id-type="pmid">33538338</pub-id></mixed-citation></ref><ref id="cit0002"><label>2.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Herrmann</surname><given-names>J</given-names></string-name>. <article-title>Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia</article-title>. <source><italic toggle="yes">Nat Rev Cardiol</italic></source>. <year>2020</year>;<volume>17</volume>:<fpage>474</fpage>&#8211;<lpage>502</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41569-020-0348-1</pub-id><pub-id pub-id-type="pmid">32231332</pub-id><pub-id pub-id-type="pmcid">PMC8782611</pub-id></mixed-citation></ref><ref id="cit0003"><label>3.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Banfill</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Giuliani</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Aznar</surname><given-names>M</given-names></string-name>, et al. <article-title>Cardiac Toxicity of Thoracic Radiotherapy: existing Evidence and Future Directions</article-title>. <source><italic toggle="yes">J Thorac Oncol</italic></source>. <year>2021</year>;<volume>16</volume>:<fpage>216</fpage>&#8211;<lpage>227</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jtho.2020.11.002</pub-id><pub-id pub-id-type="pmid">33278607</pub-id><pub-id pub-id-type="pmcid">PMC7870458</pub-id></mixed-citation></ref><ref id="cit0004"><label>4.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Tang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Pearce</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>O&#8217;Donnell-Tormey</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hubbard-Lucey</surname><given-names>VM</given-names></string-name>. <article-title>Trends in the global immuno-oncology landscape</article-title>. <source><italic toggle="yes">Nat Rev Drug Discov</italic></source>. <year>2018</year>;<volume>17</volume>:<fpage>783</fpage>&#8211;<lpage>784</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrd.2018.167</pub-id><pub-id pub-id-type="pmid">30337722</pub-id></mixed-citation></ref><ref id="cit0005"><label>5.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Liu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Fu</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wan</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Wei</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wei</surname><given-names>X</given-names></string-name>. <article-title>Cancer vaccines as promising immuno-therapeutics: platforms and current progress</article-title>. <source><italic toggle="yes">J Hematol Oncol</italic></source>. <year>2022</year>;<volume>15</volume>:<fpage>28</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13045-022-01247-x</pub-id><pub-id pub-id-type="pmid">35303904</pub-id><pub-id pub-id-type="pmcid">PMC8931585</pub-id></mixed-citation></ref><ref id="cit0006"><label>6.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Labanieh</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Mackall</surname><given-names>CL</given-names></string-name>. <article-title>CAR immune cells: design principles, resistance and the next generation</article-title>. <source><italic toggle="yes">Nature</italic></source>. <year>2023</year>;<volume>614</volume>:<fpage>635</fpage>&#8211;<lpage>648</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41586-023-05707-3</pub-id><pub-id pub-id-type="pmid">36813894</pub-id></mixed-citation></ref><ref id="cit0007"><label>7.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Zhang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>X</given-names></string-name>, et al. <article-title>A Peritumorally Injected Immunomodulating Adjuvant Elicits Robust and Safe Metalloimmunotherapy against Solid Tumors</article-title>. <source><italic toggle="yes">Adv Mater</italic></source>. <year>2022</year>: <volume>34</volume>:<fpage>e2206915</fpage>. doi:<pub-id pub-id-type="doi">10.1002/adma.202206915</pub-id><pub-id pub-id-type="pmid">35986645</pub-id></mixed-citation></ref><ref id="cit0008"><label>8.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Wang</surname><given-names>DR</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>XL</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>YL</given-names></string-name>. <article-title>Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response</article-title>. <source><italic toggle="yes">Signal Transduct Target Ther</italic></source>. <year>2022</year>;<volume>7</volume>:<fpage>331</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41392-022-01136-2</pub-id><pub-id pub-id-type="pmid">36123348</pub-id><pub-id pub-id-type="pmcid">PMC9485144</pub-id></mixed-citation></ref><ref id="cit0009"><label>9.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>He</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>C</given-names></string-name>. <article-title>Immune checkpoint signaling and cancer immunotherapy</article-title>. <source><italic toggle="yes">Cell Res</italic></source>. <year>2020</year>;<volume>30</volume>:<fpage>660</fpage>&#8211;<lpage>669</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41422-020-0343-4</pub-id><pub-id pub-id-type="pmid">32467592</pub-id><pub-id pub-id-type="pmcid">PMC7395714</pub-id></mixed-citation></ref><ref id="cit0010"><label>10.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Rui</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>He</surname><given-names>S</given-names></string-name>. <article-title>Cancer immunotherapies: advances and bottlenecks</article-title>. <source><italic toggle="yes">Front Immunol</italic></source>. <year>2023</year>;<volume>14</volume>:<fpage>1212476</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2023.1212476</pub-id><pub-id pub-id-type="pmid">37691932</pub-id><pub-id pub-id-type="pmcid">PMC10484345</pub-id></mixed-citation></ref><ref id="cit0011"><label>11.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Ferris</surname><given-names>RL</given-names></string-name>. <article-title>Immunology and Immunotherapy of Head and Neck Cancer</article-title>. <source><italic toggle="yes">J Clin Oncol</italic></source>. <year>2015</year>;<volume>33</volume>:<fpage>3293</fpage>&#8211;<lpage>3304</lpage>. doi:<pub-id pub-id-type="doi">10.1200/jco.2015.61.1509</pub-id><pub-id pub-id-type="pmid">26351330</pub-id><pub-id pub-id-type="pmcid">PMC4586169</pub-id></mixed-citation></ref><ref id="cit0012"><label>12.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Manca</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Raez</surname><given-names>LE</given-names></string-name>, <string-name name-style="western"><surname>Salzberg</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Sanchez</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hunis</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Rolfo</surname><given-names>C</given-names></string-name>. <article-title>The value of immunotherapy in head and neck cancer</article-title>. <source><italic toggle="yes">Expert Opin Biol Ther</italic></source>. <year>2019</year>;<volume>19</volume>:<fpage>35</fpage>&#8211;<lpage>43</lpage>. doi:<pub-id pub-id-type="doi">10.1080/14712598.2019.1556637</pub-id><pub-id pub-id-type="pmid">30537444</pub-id></mixed-citation></ref><ref id="cit0013"><label>13.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Hegde</surname><given-names>PS</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>DS</given-names></string-name>. <article-title>Top 10 Challenges in Cancer Immunotherapy</article-title>. <source><italic toggle="yes">Immunity</italic></source>. <year>2020</year>;<volume>52</volume>:<fpage>17</fpage>&#8211;<lpage>35</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2019.12.011</pub-id><pub-id pub-id-type="pmid">31940268</pub-id></mixed-citation></ref><ref id="cit0014"><label>14.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Vogrig</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Mu&#241;iz-Castrillo</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Joubert</surname><given-names>B</given-names></string-name>, et al. <article-title>Central nervous system complications associated with immune checkpoint inhibitors</article-title>. <source><italic toggle="yes">J Neurol Neurosurg Psych</italic></source>. <year>2020</year>;<volume>91</volume>:<fpage>772</fpage>&#8211;<lpage>778</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jnnp-2020-323055</pub-id><pub-id pub-id-type="pmid">32312871</pub-id></mixed-citation></ref><ref id="cit0015"><label>15.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Sullivan</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Weber</surname><given-names>JS</given-names></string-name>. <article-title>Immune-related toxicities of checkpoint inhibitors: mechanisms and mitigation strategies</article-title>. <source><italic toggle="yes">Nat Rev Drug Discov</italic></source>. <year>2022</year>;<volume>21</volume>:<fpage>495</fpage>&#8211;<lpage>508</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41573-021-00259-5</pub-id><pub-id pub-id-type="pmid">34316029</pub-id></mixed-citation></ref><ref id="cit0016"><label>16.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Dougan</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Luoma</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Dougan</surname><given-names>SK</given-names></string-name>, <string-name name-style="western"><surname>Wucherpfennig</surname><given-names>KW</given-names></string-name>. <article-title>Understanding and treating the inflammatory adverse events of cancer immunotherapy</article-title>. <source><italic toggle="yes">Cell</italic></source>. <year>2021</year>;<volume>184</volume>:<fpage>1575</fpage>&#8211;<lpage>1588</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2021.02.011</pub-id><pub-id pub-id-type="pmid">33675691</pub-id><pub-id pub-id-type="pmcid">PMC7979511</pub-id></mixed-citation></ref><ref id="cit0017"><label>17.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Kochanowsky</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Koshy</surname><given-names>AA</given-names></string-name>. <article-title>Toxoplasma gondii</article-title>. <source><italic toggle="yes">Curr Biol</italic></source>. <year>2018</year>; <volume>28</volume>:<fpage>R770</fpage>&#8211;<lpage>r771</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cub.2018.05.035</pub-id><pub-id pub-id-type="pmid">30040931</pub-id></mixed-citation></ref><ref id="cit0018"><label>18.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Elsheikha</surname><given-names>HM</given-names></string-name>, <string-name name-style="western"><surname>Marra</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>XQ</given-names></string-name>. <article-title>Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis</article-title>. <source><italic toggle="yes">Clin Microbiol Rev</italic></source>. <year>2021</year>;<volume>34</volume>:<fpage>e00115</fpage>&#8211;<lpage>00119</lpage>. doi:<pub-id pub-id-type="doi">10.1128/cmr.00115-19</pub-id><pub-id pub-id-type="pmid">33239310</pub-id><pub-id pub-id-type="pmcid">PMC7690944</pub-id></mixed-citation></ref><ref id="cit0019"><label>19.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Chen</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Liao</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Peng</surname><given-names>H</given-names></string-name>. <article-title>Toxoplasma gondii infection possibly reverses host immunosuppression to restrain tumor growth</article-title>. <source><italic toggle="yes">Front Cell Infect Microbiol</italic></source>. <year>2022</year>;<volume>12</volume>:<fpage>959300</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fcimb.2022.959300</pub-id><pub-id pub-id-type="pmid">36118042</pub-id><pub-id pub-id-type="pmcid">PMC9470863</pub-id></mixed-citation></ref><ref id="cit0020"><label>20.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Dupont</surname><given-names>CD</given-names></string-name>, <string-name name-style="western"><surname>Christian</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Selleck</surname><given-names>EM</given-names></string-name>, et al. <article-title>Parasite fate and involvement of infected cells in the induction of CD4+ and CD8+ T cell responses to Toxoplasma gondii</article-title>. <source><italic toggle="yes">PLoS Pathog</italic></source>. <year>2014</year>; <volume>10</volume>:<fpage>e1004047</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1004047</pub-id><pub-id pub-id-type="pmid">24722202</pub-id><pub-id pub-id-type="pmcid">PMC3983043</pub-id></mixed-citation></ref><ref id="cit0021"><label>21.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Baird</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Byrne</surname><given-names>KT</given-names></string-name>, <string-name name-style="western"><surname>Lizotte</surname><given-names>PH</given-names></string-name>, et al. <article-title>Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge</article-title>. <source><italic toggle="yes">J Immunol</italic></source>. <year>2013</year>;<volume>190</volume>:<fpage>469</fpage>&#8211;<lpage>478</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.1201209</pub-id><pub-id pub-id-type="pmid">23225891</pub-id><pub-id pub-id-type="pmcid">PMC3529845</pub-id></mixed-citation></ref><ref id="cit0022"><label>22.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Matta</surname><given-names>SK</given-names></string-name>, <string-name name-style="western"><surname>Rinkenberger</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Dunay</surname><given-names>IR</given-names></string-name>, <string-name name-style="western"><surname>Sibley</surname><given-names>LD</given-names></string-name>. <article-title>Toxoplasma gondii infection and its implications within the central nervous system</article-title>. <source><italic toggle="yes">Nat Rev Microbiol</italic></source>. <year>2021</year>;<volume>19</volume>:<fpage>467</fpage>&#8211;<lpage>480</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41579-021-00518-7</pub-id><pub-id pub-id-type="pmid">33627834</pub-id></mixed-citation></ref><ref id="cit0023"><label>23.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Fox</surname><given-names>BA</given-names></string-name>, <string-name name-style="western"><surname>Bzik</surname><given-names>DJ</given-names></string-name>. <article-title>De novo pyrimidine biosynthesis is required for virulence of Toxoplasma gondii</article-title>. <source><italic toggle="yes">Nature</italic></source>. <year>2002</year>;<volume>415</volume>:<fpage>926</fpage>&#8211;<lpage>929</lpage>. doi:<pub-id pub-id-type="doi">10.1038/415926a</pub-id><pub-id pub-id-type="pmid">11859373</pub-id></mixed-citation></ref><ref id="cit0024"><label>24.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Fox</surname><given-names>BA</given-names></string-name>, <string-name name-style="western"><surname>Sanders</surname><given-names>KL</given-names></string-name>, <string-name name-style="western"><surname>Rommereim</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Guevara</surname><given-names>RB</given-names></string-name>, <string-name name-style="western"><surname>Bzik</surname><given-names>DJ</given-names></string-name>. <article-title>Secretion of Rhoptry and Dense Granule Effector Proteins by Nonreplicating Toxoplasma gondii Uracil Auxotrophs Controls the Development of Antitumor Immunity</article-title>. <source><italic toggle="yes">PLoS Genet</italic></source>. <year>2016</year>; <volume>12</volume>:<fpage>e1006189</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pgen.1006189</pub-id><pub-id pub-id-type="pmid">27447180</pub-id><pub-id pub-id-type="pmcid">PMC4957766</pub-id></mixed-citation></ref><ref id="cit0025"><label>25.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Pegtel</surname><given-names>DM</given-names></string-name>, <string-name name-style="western"><surname>Gould</surname><given-names>SJ</given-names></string-name>. <article-title>Exosomes</article-title>. <source><italic toggle="yes">Annu Rev Biochem</italic></source>. <year>2019</year>;<volume>88</volume>:<fpage>487</fpage>&#8211;<lpage>514</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev-biochem-013118-111902</pub-id><pub-id pub-id-type="pmid">31220978</pub-id></mixed-citation></ref><ref id="cit0026"><label>26.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Li</surname><given-names>DL</given-names></string-name>, <string-name name-style="western"><surname>Zou</surname><given-names>WH</given-names></string-name>, <string-name name-style="western"><surname>Deng</surname><given-names>SQ</given-names></string-name>, <string-name name-style="western"><surname>Peng</surname><given-names>HJ</given-names></string-name>. <article-title>Analysis of the Differential Exosomal miRNAs of DC2.4 Dendritic Cells Induced by Toxoplasma gondii Infection</article-title>. <source><italic toggle="yes">Int J Mol Sci</italic></source>. <year>2019</year>;<volume>20</volume>:<fpage>5506</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms20215506</pub-id><pub-id pub-id-type="pmid">31694199</pub-id><pub-id pub-id-type="pmcid">PMC6862309</pub-id></mixed-citation></ref><ref id="cit0027"><label>27.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Mashouri</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Yousefi</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Aref</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Ahadi</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Molaei</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Alahari</surname><given-names>SK</given-names></string-name>. <article-title>Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance</article-title>. <source><italic toggle="yes">Mol Cancer</italic></source>. <year>2019</year>;<volume>18</volume>:<fpage>75</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12943-019-0991-5</pub-id><pub-id pub-id-type="pmid">30940145</pub-id><pub-id pub-id-type="pmcid">PMC6444571</pub-id></mixed-citation></ref><ref id="cit0028"><label>28.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Kalluri</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>LeBleu</surname><given-names>VS</given-names></string-name>. <article-title>The biology, function, and biomedical applications of exosomes</article-title>. <source><italic toggle="yes">Science</italic></source>. <year>2020</year>;<volume>367</volume>:<fpage>eaau6977</fpage>. doi:<pub-id pub-id-type="doi">10.1126/science.aau6977</pub-id><pub-id pub-id-type="pmid">32029601</pub-id><pub-id pub-id-type="pmcid">PMC7717626</pub-id></mixed-citation></ref><ref id="cit0029"><label>29.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Nanbo</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kawanishi</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Yoshida</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Yoshiyama</surname><given-names>H</given-names></string-name>. <article-title>Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells</article-title>. <source><italic toggle="yes">J Virol</italic></source>. <year>2013</year>;<volume>87</volume>:<fpage>10334</fpage>&#8211;<lpage>10347</lpage>. doi:<pub-id pub-id-type="doi">10.1128/jvi.01310-13</pub-id><pub-id pub-id-type="pmid">23864627</pub-id><pub-id pub-id-type="pmcid">PMC3753980</pub-id></mixed-citation></ref><ref id="cit0030"><label>30.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Svensson</surname><given-names>KJ</given-names></string-name>, <string-name name-style="western"><surname>Christianson</surname><given-names>HC</given-names></string-name>, <string-name name-style="western"><surname>Wittrup</surname><given-names>A</given-names></string-name>, et al. <article-title>Exosome uptake depends on ERK1/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-1</article-title>. <source><italic toggle="yes">J Biol Chem</italic></source>. <year>2013</year>;<volume>288</volume>:<fpage>17713</fpage>&#8211;<lpage>17724</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M112.445403</pub-id><pub-id pub-id-type="pmid">23653359</pub-id><pub-id pub-id-type="pmcid">PMC3682571</pub-id></mixed-citation></ref><ref id="cit0031"><label>31.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Maus</surname><given-names>RLG</given-names></string-name>, <string-name name-style="western"><surname>Jakub</surname><given-names>JW</given-names></string-name>, <string-name name-style="western"><surname>Nevala</surname><given-names>WK</given-names></string-name>, et al. <article-title>Human Melanoma-Derived Extracellular Vesicles Regulate Dendritic Cell Maturation</article-title>. <source><italic toggle="yes">Front Immunol</italic></source>. <year>2017</year>;<volume>8</volume>:<fpage>358</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2017.00358</pub-id><pub-id pub-id-type="pmid">28424693</pub-id><pub-id pub-id-type="pmcid">PMC5372822</pub-id></mixed-citation></ref><ref id="cit0032"><label>32.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Becker</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Thakur</surname><given-names>BK</given-names></string-name>, <string-name name-style="western"><surname>Weiss</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>HS</given-names></string-name>, <string-name name-style="western"><surname>Peinado</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Lyden</surname><given-names>D</given-names></string-name>. <article-title>Extracellular Vesicles in Cancer: cell-to-Cell Mediators of Metastasis</article-title>. <source><italic toggle="yes">Cancer Cell</italic></source>. <year>2016</year>;<volume>30</volume>:<fpage>836</fpage>&#8211;<lpage>848</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ccell.2016.10.009</pub-id><pub-id pub-id-type="pmid">27960084</pub-id><pub-id pub-id-type="pmcid">PMC5157696</pub-id></mixed-citation></ref><ref id="cit0033"><label>33.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Siravegna</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Marsoni</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Siena</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Bardelli</surname><given-names>A</given-names></string-name>. <article-title>Integrating liquid biopsies into the management of cancer</article-title>. <source><italic toggle="yes">Nat Rev Clin Oncol</italic></source>. <year>2017</year>;<volume>14</volume>:<fpage>531</fpage>&#8211;<lpage>548</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrclinonc.2017.14</pub-id><pub-id pub-id-type="pmid">28252003</pub-id></mixed-citation></ref><ref id="cit0034"><label>34.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Lee</surname><given-names>NK</given-names></string-name>, <string-name name-style="western"><surname>Kothandan</surname><given-names>VK</given-names></string-name>, <string-name name-style="western"><surname>Kothandan</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Byun</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Hwang</surname><given-names>SR</given-names></string-name>. <article-title>Exosomes and Cancer Stem Cells in Cancer Immunity: current Reports and Future Directions</article-title>. <source><italic toggle="yes">Vaccines</italic></source>. <year>2021</year>;<volume>9</volume>:<fpage>441</fpage>. doi:<pub-id pub-id-type="doi">10.3390/vaccines9050441</pub-id><pub-id pub-id-type="pmid">34062950</pub-id><pub-id pub-id-type="pmcid">PMC8147426</pub-id></mixed-citation></ref><ref id="cit0035"><label>35.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Buscail</surname><given-names>L</given-names></string-name>. <article-title>Pancreatic cancer: exosomes for targeting KRAS in the treatment of pancreatic cancer</article-title>. <source><italic toggle="yes">Nat Rev Gastroenterol Hepatol</italic></source>. <year>2017</year>;<volume>14</volume>:<fpage>636</fpage>&#8211;<lpage>638</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrgastro.2017.113</pub-id><pub-id pub-id-type="pmid">28874835</pub-id></mixed-citation></ref><ref id="cit0036"><label>36.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Smith</surname><given-names>ZJ</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Rojalin</surname><given-names>T</given-names></string-name>, et al. <article-title>Single exosome study reveals subpopulations distributed among cell lines with variability related to membrane content</article-title>. <source><italic toggle="yes">J Extracell Vesicles</italic></source>. <year>2015</year>;<volume>4</volume>:<fpage>28533</fpage>. doi:<pub-id pub-id-type="doi">10.3402/jev.v4.28533</pub-id><pub-id pub-id-type="pmid">26649679</pub-id><pub-id pub-id-type="pmcid">PMC4673914</pub-id></mixed-citation></ref><ref id="cit0037"><label>37.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Silva</surname><given-names>VO</given-names></string-name>, <string-name name-style="western"><surname>Maia</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>Torrecilhas</surname><given-names>AC</given-names></string-name>, et al. <article-title>Extracellular vesicles isolated from Toxoplasma gondii induce host immune response</article-title>. <source><italic toggle="yes">Parasite Immunol</italic></source>. <year>2018</year>;<volume>40</volume>:<fpage>e12571</fpage>. doi:<pub-id pub-id-type="doi">10.1111/pim.12571</pub-id><pub-id pub-id-type="pmid">29974519</pub-id></mixed-citation></ref><ref id="cit0038"><label>38.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Schorey</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Singh</surname><given-names>PP</given-names></string-name>, <string-name name-style="western"><surname>Smith</surname><given-names>VL</given-names></string-name>. <article-title>Exosomes and other extracellular vesicles in host-pathogen interactions</article-title>. <source><italic toggle="yes">EMBO Rep</italic></source>. <year>2015</year>;<volume>16</volume>:<fpage>24</fpage>&#8211;<lpage>43</lpage>. doi:<pub-id pub-id-type="doi">10.15252/embr.201439363</pub-id><pub-id pub-id-type="pmid">25488940</pub-id><pub-id pub-id-type="pmcid">PMC4304727</pub-id></mixed-citation></ref><ref id="cit0039"><label>39.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Th&#233;ry</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Duban</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Segura</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>V&#233;ron</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Lantz</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Amigorena</surname><given-names>S</given-names></string-name>. <article-title>Indirect activation of na&#239;ve CD4+ T cells by dendritic cell-derived exosomes</article-title>. <source><italic toggle="yes">Nat Immunol</italic></source>. <year>2002</year>;<volume>3</volume>:<fpage>1156</fpage>&#8211;<lpage>1162</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ni854</pub-id><pub-id pub-id-type="pmid">12426563</pub-id></mixed-citation></ref><ref id="cit0040"><label>40.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Lourido</surname><given-names>S</given-names></string-name>. <article-title>Toxoplasma gondii</article-title>. <source><italic toggle="yes">Trends Parasitol</italic></source>. <year>2019</year>;<volume>35</volume>:<fpage>944</fpage>&#8211;<lpage>945</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pt.2019.07.001</pub-id><pub-id pub-id-type="pmid">31345768</pub-id></mixed-citation></ref><ref id="cit0041"><label>41.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Harker</surname><given-names>KS</given-names></string-name>, <string-name name-style="western"><surname>Ueno</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Lodoen</surname><given-names>MB</given-names></string-name>. <article-title>Toxoplasma gondii dissemination: a parasite&#8217;s journey through the infected host</article-title>. <source><italic toggle="yes">Parasite Immunol</italic></source>. <year>2015</year>;<volume>37</volume>:<fpage>141</fpage>&#8211;<lpage>149</lpage>. doi:<pub-id pub-id-type="doi">10.1111/pim.12163</pub-id><pub-id pub-id-type="pmid">25408224</pub-id></mixed-citation></ref><ref id="cit0042"><label>42.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Sasai</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Pradipta</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Yamamoto</surname><given-names>M</given-names></string-name>. <article-title>Host immune responses to Toxoplasma gondii</article-title>. <source><italic toggle="yes">Int Immunol</italic></source>. <year>2018</year>;<volume>30</volume>:<fpage>113</fpage>&#8211;<lpage>119</lpage>. doi:<pub-id pub-id-type="doi">10.1093/intimm/dxy004</pub-id><pub-id pub-id-type="pmid">29408976</pub-id></mixed-citation></ref><ref id="cit0043"><label>43.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Conley</surname><given-names>FK</given-names></string-name>, <string-name name-style="western"><surname>Remington</surname><given-names>JS</given-names></string-name>. <article-title>Nonspecific inhibition of tumor growth in the central nervous system: observations of intracerebral ependymoblastoma in mice with chronic Toxoplasma infection</article-title>. <source><italic toggle="yes">J Natl Cancer Inst</italic></source>. <year>1977</year>;<volume>59</volume>:<fpage>963</fpage>&#8211;<lpage>973</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jnci/59.3.963</pub-id><pub-id pub-id-type="pmid">894752</pub-id></mixed-citation></ref><ref id="cit0044"><label>44.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Conley</surname><given-names>FK</given-names></string-name>. <article-title>Influence of chronic Toxoplasma infection on ethylnitrosourea-induced central nervous system tumors in rats</article-title>. <source><italic toggle="yes">Cancer Res</italic></source>. <year>1980</year>;<volume>40</volume>:<fpage>1240</fpage>&#8211;<lpage>1244</lpage>.<pub-id pub-id-type="pmid">7357553</pub-id></mixed-citation></ref><ref id="cit0045"><label>45.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Hunter</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Sibley</surname><given-names>LD</given-names></string-name>. <article-title>Modulation of innate immunity by Toxoplasma gondii virulence effectors</article-title>. <source><italic toggle="yes">Nat Rev Microbiol</italic></source>. <year>2012</year>;<volume>10</volume>:<fpage>766</fpage>&#8211;<lpage>778</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrmicro2858</pub-id><pub-id pub-id-type="pmid">23070557</pub-id><pub-id pub-id-type="pmcid">PMC3689224</pub-id></mixed-citation></ref><ref id="cit0046"><label>46.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Hunter</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Subauste</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Van Cleave</surname><given-names>VH</given-names></string-name>, <string-name name-style="western"><surname>Remington</surname><given-names>JS</given-names></string-name>. <article-title>Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha</article-title>. <source><italic toggle="yes">Infect Immun</italic></source>. <year>1994</year>;<volume>62</volume>:<fpage>2818</fpage>&#8211;<lpage>2824</lpage>. doi:<pub-id pub-id-type="doi">10.1128/iai.62.7.2818-2824.1994</pub-id><pub-id pub-id-type="pmid">7911785</pub-id><pub-id pub-id-type="pmcid">PMC302887</pub-id></mixed-citation></ref><ref id="cit0047"><label>47.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Sasai</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Yamamoto</surname><given-names>M</given-names></string-name>. <article-title>Pathogen recognition receptors: ligands and signaling pathways by Toll-like receptors</article-title>. <source><italic toggle="yes">Int Rev Immunol</italic></source>. <year>2013</year>;<volume>32</volume>:<fpage>116</fpage>&#8211;<lpage>133</lpage>. doi:<pub-id pub-id-type="doi">10.3109/08830185.2013.774391</pub-id><pub-id pub-id-type="pmid">23570313</pub-id></mixed-citation></ref><ref id="cit0048"><label>48.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Koblansky</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Jankovic</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Oh</surname><given-names>H</given-names></string-name>, et al. <article-title>Recognition of profilin by Toll-like receptor 12 is critical for host resistance to Toxoplasma gondii</article-title>. <source><italic toggle="yes">Immunity</italic></source>. <year>2013</year>;<volume>38</volume>:<fpage>119</fpage>&#8211;<lpage>130</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.immuni.2012.09.016</pub-id><pub-id pub-id-type="pmid">23246311</pub-id><pub-id pub-id-type="pmcid">PMC3601573</pub-id></mixed-citation></ref><ref id="cit0049"><label>49.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Plattner</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Yarovinsky</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Romero</surname><given-names>S</given-names></string-name>, et al. <article-title>Toxoplasma profilin is essential for host cell invasion and TLR11-dependent induction of an interleukin-12 response</article-title>. <source><italic toggle="yes">Cell Host Microbe</italic></source>. <year>2008</year>;<volume>3</volume>:<fpage>77</fpage>&#8211;<lpage>87</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chom.2008.01.001</pub-id><pub-id pub-id-type="pmid">18312842</pub-id></mixed-citation></ref><ref id="cit0050"><label>50.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Scanga</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Aliberti</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Jankovic</surname><given-names>D</given-names></string-name>, et al. <article-title>Cutting edge: myD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells</article-title>. <source><italic toggle="yes">J Immunol</italic></source>. <year>2002</year>;<volume>168</volume>:<fpage>5997</fpage>&#8211;<lpage>6001</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.168.12.5997</pub-id><pub-id pub-id-type="pmid">12055206</pub-id></mixed-citation></ref><ref id="cit0051"><label>51.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Andrade</surname><given-names>WA</given-names></string-name>, <string-name name-style="western"><surname>Souza Mdo</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Ramos-Martinez</surname><given-names>E</given-names></string-name>, et al. <article-title>Combined action of nucleic acid-sensing Toll-like receptors and TLR11/TLR12&#160;heterodimers imparts resistance to Toxoplasma gondii in mice</article-title>. <source><italic toggle="yes">Cell Host Microbe</italic></source>. <year>2013</year>;<volume>13</volume>:<fpage>42</fpage>&#8211;<lpage>53</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chom.2012.12.003</pub-id><pub-id pub-id-type="pmid">23290966</pub-id><pub-id pub-id-type="pmcid">PMC3552114</pub-id></mixed-citation></ref><ref id="cit0052"><label>52.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Mahmoudzadeh</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Nozad Charoudeh</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Marques</surname><given-names>CS</given-names></string-name>, <string-name name-style="western"><surname>Bahadory</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ahmadpour</surname><given-names>E</given-names></string-name>. <article-title>The role of IL-12 in stimulating NK cells against Toxoplasma gondii infection: a mini-review</article-title>. <source><italic toggle="yes">Parasitol Res</italic></source>. <year>2021</year>;<volume>120</volume>:<fpage>2303</fpage>&#8211;<lpage>2309</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00436-021-07204-w</pub-id><pub-id pub-id-type="pmid">34110502</pub-id></mixed-citation></ref><ref id="cit0053"><label>53.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Gazzinelli</surname><given-names>RT</given-names></string-name>, <string-name name-style="western"><surname>Hieny</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Wynn</surname><given-names>TA</given-names></string-name>, <string-name name-style="western"><surname>Wolf</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Sher</surname><given-names>A</given-names></string-name>. <article-title>Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts</article-title>. <source><italic toggle="yes">Proc Natl Acad Sci U S A</italic></source>. <year>1993</year>;<volume>90</volume>:<fpage>6115</fpage>&#8211;<lpage>6119</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.90.13.6115</pub-id><pub-id pub-id-type="pmid">8100999</pub-id><pub-id pub-id-type="pmcid">PMC46878</pub-id></mixed-citation></ref><ref id="cit0054"><label>54.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Khan</surname><given-names>IA</given-names></string-name>, <string-name name-style="western"><surname>Matsuura</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Kasper</surname><given-names>LH</given-names></string-name>. <article-title>Interleukin-12 enhances murine survival against acute toxoplasmosis</article-title>. <source><italic toggle="yes">Infect Immun</italic></source>. <year>1994</year>;<volume>62</volume>:<fpage>1639</fpage>&#8211;<lpage>1642</lpage>. doi:<pub-id pub-id-type="doi">10.1128/iai.62.5.1639-1642.1994</pub-id><pub-id pub-id-type="pmid">7909536</pub-id><pub-id pub-id-type="pmcid">PMC186373</pub-id></mixed-citation></ref><ref id="cit0055"><label>55.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Ma</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Sasai</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ohshima</surname><given-names>J</given-names></string-name>, et al. <article-title>Selective and strain-specific NFAT4 activation by the Toxoplasma gondii polymorphic dense granule protein GRA6</article-title>. <source><italic toggle="yes">J Exp Med</italic></source>. <year>2014</year>;<volume>211</volume>:<fpage>2013</fpage>&#8211;<lpage>2032</lpage>. doi:<pub-id pub-id-type="doi">10.1084/jem.20131272</pub-id><pub-id pub-id-type="pmid">25225460</pub-id><pub-id pub-id-type="pmcid">PMC4172224</pub-id></mixed-citation></ref><ref id="cit0056"><label>56.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Klose</surname><given-names>CSN</given-names></string-name>, <string-name name-style="western"><surname>Flach</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>M&#246;hle</surname><given-names>L</given-names></string-name>, et al. <article-title>Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages</article-title>. <source><italic toggle="yes">Cell</italic></source>. <year>2014</year>;<volume>157</volume>:<fpage>340</fpage>&#8211;<lpage>356</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2014.03.030</pub-id><pub-id pub-id-type="pmid">24725403</pub-id></mixed-citation></ref><ref id="cit0057"><label>57.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Lima</surname><given-names>TS</given-names></string-name>, <string-name name-style="western"><surname>Lodoen</surname><given-names>MB</given-names></string-name>. <article-title>Mechanisms of Human Innate Immune Evasion by Toxoplasma gondii</article-title>. <source><italic toggle="yes">Front Cell Infect Microbiol</italic></source>. <year>2019</year>;<volume>9</volume>:<fpage>103</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fcimb.2019.00103</pub-id><pub-id pub-id-type="pmid">31041194</pub-id><pub-id pub-id-type="pmcid">PMC6476913</pub-id></mixed-citation></ref><ref id="cit0058"><label>58.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Hunter</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Gee</surname><given-names>M</given-names></string-name>, et al. <article-title>Cutting edge: systemic inhibition of angiogenesis underlies resistance to tumors during acute toxoplasmosis</article-title>. <source><italic toggle="yes">J Immunol</italic></source>. <year>2001</year>;<volume>166</volume>:<fpage>5878</fpage>&#8211;<lpage>5881</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.166.10.5878</pub-id><pub-id pub-id-type="pmid">11342601</pub-id></mixed-citation></ref><ref id="cit0059"><label>59.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Kim</surname><given-names>JO</given-names></string-name>, <string-name name-style="western"><surname>Jung</surname><given-names>SS</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>SY</given-names></string-name>, et al. <article-title>Inhibition of Lewis lung carcinoma growth by Toxoplasma gondii through induction of Th1 immune responses and inhibition of angiogenesis</article-title>. <source><italic toggle="yes">J Korean Med Sci</italic></source>. <year>2007</year>:<fpage>S38</fpage>&#8211;<lpage>46</lpage>. doi:<pub-id pub-id-type="doi">10.3346/jkms.2007.22.S.S38</pub-id><pub-id pub-id-type="pmid">17923753</pub-id><pub-id pub-id-type="pmcid">PMC2694397</pub-id></mixed-citation></ref><ref id="cit0060"><label>60.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Zhu</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Lu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>Z</given-names></string-name>, et al. <article-title>Anti-Tumoral Effect and Action Mechanism of Exosomes Derived From Toxoplasma gondii-Infected Dendritic Cells in Mice Colorectal Cancer</article-title>. <source><italic toggle="yes">Front Oncol</italic></source>. <year>2022</year>;<volume>12</volume>:<fpage>870528</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fonc.2022.870528</pub-id><pub-id pub-id-type="pmid">35600340</pub-id><pub-id pub-id-type="pmcid">PMC9118538</pub-id></mixed-citation></ref><ref id="cit0061"><label>61.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Fox</surname><given-names>BA</given-names></string-name>, <string-name name-style="western"><surname>Bzik</surname><given-names>DJ</given-names></string-name>. <article-title>Avirulent uracil auxotrophs based on disruption of orotidine-5&#8217;-monophosphate decarboxylase elicit protective immunity to Toxoplasma gondii</article-title>. <source><italic toggle="yes">Infect Immun</italic></source>. <year>2010</year>;<volume>78</volume>:<fpage>3744</fpage>&#8211;<lpage>3752</lpage>. doi:<pub-id pub-id-type="doi">10.1128/iai.00287-10</pub-id><pub-id pub-id-type="pmid">20605980</pub-id><pub-id pub-id-type="pmcid">PMC2937452</pub-id></mixed-citation></ref><ref id="cit0062"><label>62.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Baird</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Fox</surname><given-names>BA</given-names></string-name>, <string-name name-style="western"><surname>Sanders</surname><given-names>KL</given-names></string-name>, et al. <article-title>Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment</article-title>. <source><italic toggle="yes">Cancer Res</italic></source>. <year>2013</year>;<volume>73</volume>:<fpage>3842</fpage>&#8211;<lpage>3851</lpage>. doi:<pub-id pub-id-type="doi">10.1158/0008-5472.Can-12-1974</pub-id><pub-id pub-id-type="pmid">23704211</pub-id><pub-id pub-id-type="pmcid">PMC3702636</pub-id></mixed-citation></ref><ref id="cit0063"><label>63.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Sanders</surname><given-names>KL</given-names></string-name>, <string-name name-style="western"><surname>Fox</surname><given-names>BA</given-names></string-name>, <string-name name-style="western"><surname>Bzik</surname><given-names>DJ</given-names></string-name>. <article-title>Attenuated Toxoplasma gondii Stimulates Immunity to Pancreatic Cancer by Manipulation of Myeloid Cell Populations</article-title>. <source><italic toggle="yes">Cancer Immunol Res</italic></source>. <year>2015</year>;<volume>3</volume>:<fpage>891</fpage>&#8211;<lpage>901</lpage>. doi:<pub-id pub-id-type="doi">10.1158/2326-6066.Cir-14-0235</pub-id><pub-id pub-id-type="pmid">25804437</pub-id><pub-id pub-id-type="pmcid">PMC4526316</pub-id></mixed-citation></ref><ref id="cit0064"><label>64.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Xu</surname><given-names>LQ</given-names></string-name>, <string-name name-style="western"><surname>Yao</surname><given-names>LJ</given-names></string-name>, <string-name name-style="western"><surname>Jiang</surname><given-names>D</given-names></string-name>, et al. <article-title>A uracil auxotroph Toxoplasma gondii exerting immunomodulation to inhibit breast cancer growth and metastasis</article-title>. <source><italic toggle="yes">Parasit Vectors</italic></source>. <year>2021</year>;<volume>14</volume>:<fpage>601</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13071-021-05032-6</pub-id><pub-id pub-id-type="pmid">34895326</pub-id><pub-id pub-id-type="pmcid">PMC8665513</pub-id></mixed-citation></ref><ref id="cit0065"><label>65.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Yang</surname><given-names>MP</given-names></string-name>, <string-name name-style="western"><surname>Goitsuka</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Ono</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Suzuki</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Hasegawa</surname><given-names>A</given-names></string-name>. <article-title>Effect of Toxoplasma lysate antigen (TLA) on feline cytotoxicity against FeLV positive lymphoma cells</article-title>. <source><italic toggle="yes">Nihon Juigaku Zasshi</italic></source>. <year>1990</year>;<volume>52</volume>:<fpage>735</fpage>&#8211;<lpage>742</lpage>. doi:<pub-id pub-id-type="doi">10.1292/jvms1939.52.735</pub-id><pub-id pub-id-type="pmid">2167995</pub-id></mixed-citation></ref><ref id="cit0066"><label>66.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Miyahara</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Yokoo</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Sakurai</surname><given-names>H</given-names></string-name>, et al. <article-title>Antitumor activity of Toxoplasma lysate antigen against methylcholanthrene-induced tumor-bearing rats</article-title>. <source><italic toggle="yes">J Vet Med Sci</italic></source>. <year>1992</year>;<volume>54</volume>:<fpage>221</fpage>&#8211;<lpage>228</lpage>. doi:<pub-id pub-id-type="doi">10.1292/jvms.54.221</pub-id><pub-id pub-id-type="pmid">1606251</pub-id></mixed-citation></ref><ref id="cit0067"><label>67.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Pyo</surname><given-names>KH</given-names></string-name>, <string-name name-style="western"><surname>Jung</surname><given-names>BK</given-names></string-name>, <string-name name-style="western"><surname>Xin</surname><given-names>CF</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>YW</given-names></string-name>, <string-name name-style="western"><surname>Chai</surname><given-names>JY</given-names></string-name>, <string-name name-style="western"><surname>Shin</surname><given-names>EH</given-names></string-name>. <article-title>Prominent IL-12 production and tumor reduction in athymic nude mice after Toxoplasma gondii lysate antigen treatment</article-title>. <source><italic toggle="yes">Korean J Parasitol</italic></source>. <year>2014</year>;<volume>52</volume>:<fpage>605</fpage>&#8211;<lpage>612</lpage>. doi:<pub-id pub-id-type="doi">10.3347/kjp.2014.52.6.605</pub-id><pub-id pub-id-type="pmid">25548411</pub-id><pub-id pub-id-type="pmcid">PMC4277022</pub-id></mixed-citation></ref><ref id="cit0068"><label>68.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Motamedi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Arab</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Moazzeni</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Khamis Abadi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hadjati</surname><given-names>J</given-names></string-name>. <article-title>Improvement of a dendritic cell-based therapeutic cancer vaccine with components of Toxoplasma gondii</article-title>. <source><italic toggle="yes">Clin Vaccine Immunol</italic></source>. <year>2009</year>;<volume>16</volume>:<fpage>1393</fpage>&#8211;<lpage>1398</lpage>. doi:<pub-id pub-id-type="doi">10.1128/cvi.00199-09</pub-id><pub-id pub-id-type="pmid">19656994</pub-id><pub-id pub-id-type="pmcid">PMC2756855</pub-id></mixed-citation></ref><ref id="cit0069"><label>69.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Boghozian</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Saei</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Mirzaei</surname><given-names>R</given-names></string-name>, et al. <article-title>Identification of Toxoplasma gondii protein fractions induce immune response against melanoma in mice</article-title>. <source><italic toggle="yes">Apmis</italic></source>. <year>2015</year>;<volume>123</volume>:<fpage>800</fpage>&#8211;<lpage>809</lpage>. doi:<pub-id pub-id-type="doi">10.1111/apm.12420</pub-id><pub-id pub-id-type="pmid">26152792</pub-id></mixed-citation></ref><ref id="cit0070"><label>70.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Poppoe</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>J</given-names></string-name>, et al. <article-title>Macrophages Polarized by Expression of ToxoGRA15(II) Inhibit Growth of Hepatic Carcinoma</article-title>. <source><italic toggle="yes">Front Immunol</italic></source>. <year>2017</year>;<volume>8</volume>:<fpage>137</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2017.00137</pub-id><pub-id pub-id-type="pmid">28243242</pub-id><pub-id pub-id-type="pmcid">PMC5303709</pub-id></mixed-citation></ref><ref id="cit0071"><label>71.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Xie</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wen</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Yan</surname><given-names>K</given-names></string-name>, et al. <article-title>Toxoplasma gondii GRA15(II) effector-induced M1 cells ameliorate liver fibrosis in mice infected with Schistosomiasis japonica</article-title>. <source><italic toggle="yes">Cell Mol Immunol</italic></source>. <year>2018</year>;<volume>15</volume>:<fpage>120</fpage>&#8211;<lpage>134</lpage>. doi:<pub-id pub-id-type="doi">10.1038/cmi.2016.21</pub-id><pub-id pub-id-type="pmid">27157496</pub-id><pub-id pub-id-type="pmcid">PMC5811674</pub-id></mixed-citation></ref><ref id="cit0072"><label>72.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Trams</surname><given-names>EG</given-names></string-name>, <string-name name-style="western"><surname>Lauter</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Salem</surname><given-names>N</given-names> Jr</string-name>, <string-name name-style="western"><surname>Heine</surname><given-names>U</given-names></string-name>. <article-title>Exfoliation of membrane ecto-enzymes in the form of micro-vesicles</article-title>. <source><italic toggle="yes">Biochim Biophys Acta</italic></source>. <year>1981</year>;<volume>645</volume>:<fpage>63</fpage>&#8211;<lpage>70</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0005-2736(81)90512-5</pub-id><pub-id pub-id-type="pmid">6266476</pub-id></mixed-citation></ref><ref id="cit0073"><label>73.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Th&#233;ry</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Zitvogel</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Amigorena</surname><given-names>S</given-names></string-name>. <article-title>Exosomes: composition, biogenesis and function</article-title>. <source><italic toggle="yes">Nat Rev Immunol</italic></source>. <year>2002</year>;<volume>2</volume>:<fpage>569</fpage>&#8211;<lpage>579</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nri855</pub-id><pub-id pub-id-type="pmid">12154376</pub-id></mixed-citation></ref><ref id="cit0074"><label>74.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Guo</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Lin</surname><given-names>X</given-names></string-name>, et al. <article-title>Establishment of a simplified dichotomic size-exclusion chromatography for isolating extracellular vesicles toward clinical applications</article-title>. <source><italic toggle="yes">J Extracell Vesicles</italic></source>. <year>2021</year>;<volume>10</volume>:<fpage>e12145</fpage>. doi:<pub-id pub-id-type="doi">10.1002/jev2.12145</pub-id><pub-id pub-id-type="pmid">34514732</pub-id><pub-id pub-id-type="pmcid">PMC8435528</pub-id></mixed-citation></ref><ref id="cit0075"><label>75.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Neves</surname><given-names>KB</given-names></string-name>, <string-name name-style="western"><surname>Rios</surname><given-names>FJ</given-names></string-name>, <string-name name-style="western"><surname>Sevilla-Montero</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Montezano</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Touyz</surname><given-names>RM</given-names></string-name>. <article-title>Exosomes and the cardiovascular system: role in cardiovascular health and disease</article-title>. <source><italic toggle="yes">J Physiol</italic></source>. <year>2023</year>;<volume>601</volume>:<fpage>4923</fpage>&#8211;<lpage>4936</lpage>. doi:<pub-id pub-id-type="doi">10.1113/JP282054</pub-id><pub-id pub-id-type="pmid">35306667</pub-id><pub-id pub-id-type="pmcid">PMC10953460</pub-id></mixed-citation></ref><ref id="cit0076"><label>76.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Zhu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>J</given-names></string-name>, et al. <article-title>MicroRNAs Are Involved in the Regulation of Ovary Development in the Pathogenic Blood Fluke Schistosoma japonicum</article-title>. <source><italic toggle="yes">PLoS Pathog</italic></source>. <year>2016</year>: <volume>12</volume>:<fpage>e1005423</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.1005423</pub-id><pub-id pub-id-type="pmid">26871705</pub-id><pub-id pub-id-type="pmcid">PMC4752461</pub-id></mixed-citation></ref><ref id="cit0077"><label>77.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Zauli</surname><given-names>RC</given-names></string-name>, <string-name name-style="western"><surname>de Souza Perez</surname><given-names>IC</given-names></string-name>, <string-name name-style="western"><surname>de Morais</surname><given-names>ACC</given-names></string-name>, et al. <article-title>Extracellular Vesicles Released by Leishmania (Leishmania) amazonensis Promastigotes with Distinct Virulence Profile Differently Modulate the Macrophage Functions</article-title>. <source><italic toggle="yes">Microorganisms</italic></source>. <year>2023</year>;<volume>11</volume>:<fpage>2973</fpage>. doi:<pub-id pub-id-type="doi">10.3390/microorganisms11122973</pub-id><pub-id pub-id-type="pmid">38138117</pub-id><pub-id pub-id-type="pmcid">PMC10746037</pub-id></mixed-citation></ref><ref id="cit0078"><label>78.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Szempruch</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Sykes</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Kieft</surname><given-names>R</given-names></string-name>, et al. <article-title>Extracellular Vesicles from Trypanosoma brucei Mediate Virulence Factor Transfer and Cause Host Anemia</article-title>. <source><italic toggle="yes">Cell</italic></source>. <year>2016</year>;<volume>164</volume>:<fpage>246</fpage>&#8211;<lpage>257</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cell.2015.11.051</pub-id><pub-id pub-id-type="pmid">26771494</pub-id><pub-id pub-id-type="pmcid">PMC4715261</pub-id></mixed-citation></ref><ref id="cit0079"><label>79.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Mota</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Oliveira</surname><given-names>AC</given-names></string-name>, <string-name name-style="western"><surname>Davoli-Ferreira</surname><given-names>M</given-names></string-name>, et al. <article-title>Neospora caninum Activates p38 MAPK as an Evasion Mechanism against Innate Immunity</article-title>. <source><italic toggle="yes">Front Microbiol</italic></source>. <year>2016</year>;<volume>7</volume>:<fpage>1456</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2016.01456</pub-id><pub-id pub-id-type="pmid">27679624</pub-id><pub-id pub-id-type="pmcid">PMC5020094</pub-id></mixed-citation></ref><ref id="cit0080"><label>80.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Chen</surname><given-names>JG</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Nie</surname><given-names>Q</given-names></string-name>, et al. <article-title>Exosome-derived long noncoding RNAs: mediators of host-Plasmodium parasite communication</article-title>. <source><italic toggle="yes">Wiley Interdiscip Rev RNA</italic></source>. <year>2023</year>;<volume>15</volume>:<fpage>e1808</fpage>. doi:<pub-id pub-id-type="doi">10.1002/wrna.1808</pub-id><pub-id pub-id-type="pmid">37553236</pub-id></mixed-citation></ref><ref id="cit0081"><label>81.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Ang</surname><given-names>JXD</given-names></string-name>, <string-name name-style="western"><surname>Kadir</surname><given-names>KA</given-names></string-name>, <string-name name-style="western"><surname>Mohamad</surname><given-names>DSA</given-names></string-name>, et al. <article-title>New vectors in northern Sarawak, Malaysian Borneo, for the zoonotic malaria parasite, Plasmodium knowlesi</article-title>. <source><italic toggle="yes">Parasit Vectors</italic></source>. <year>2020</year>;<volume>13</volume>:<fpage>472</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13071-020-04345-2</pub-id><pub-id pub-id-type="pmid">32933567</pub-id><pub-id pub-id-type="pmcid">PMC7490903</pub-id></mixed-citation></ref><ref id="cit0082"><label>82.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Wowk</surname><given-names>PF</given-names></string-name>, <string-name name-style="western"><surname>Zardo</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Miot</surname><given-names>HT</given-names></string-name>, <string-name name-style="western"><surname>Goldenberg</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Carvalho</surname><given-names>PC</given-names></string-name>, <string-name name-style="western"><surname>M&#246;rking</surname><given-names>PA</given-names></string-name>. <article-title>Proteomic profiling of extracellular vesicles secreted from Toxoplasma gondii</article-title>. <source><italic toggle="yes">Proteomics</italic></source>. <year>2017</year>;<volume>17</volume>. doi:<pub-id pub-id-type="doi">10.1002/pmic.201600477</pub-id><pub-id pub-id-type="pmid">28643940</pub-id></mixed-citation></ref><ref id="cit0083"><label>83.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Xiu</surname><given-names>F</given-names></string-name>, et al. <article-title>Characterization of exosomes derived from Toxoplasma gondii and their functions in modulating immune responses</article-title>. <source><italic toggle="yes">Int J Nanomed</italic></source>. <year>2018</year>;<volume>13</volume>:<fpage>467</fpage>&#8211;<lpage>477</lpage>. doi:<pub-id pub-id-type="doi">10.2147/ijn.S151110</pub-id><pub-id pub-id-type="pmcid">PMC5783023</pub-id><pub-id pub-id-type="pmid">29403276</pub-id></mixed-citation></ref><ref id="cit0084"><label>84.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Willms</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Caba&#241;as</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>M&#228;ger</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Wood</surname><given-names>MJA</given-names></string-name>, <string-name name-style="western"><surname>Vader</surname><given-names>P</given-names></string-name>. <article-title>Extracellular Vesicle Heterogeneity: subpopulations, Isolation Techniques, and Diverse Functions in Cancer Progression</article-title>. <source><italic toggle="yes">Front Immunol</italic></source>. <year>2018</year>;<volume>9</volume>:<fpage>738</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fimmu.2018.00738</pub-id><pub-id pub-id-type="pmid">29760691</pub-id><pub-id pub-id-type="pmcid">PMC5936763</pub-id></mixed-citation></ref><ref id="cit0085"><label>85.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Shu</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Allen</surname><given-names>CL</given-names></string-name>, et al. <article-title>Purity and yield of melanoma exosomes are dependent on isolation method</article-title>. <source><italic toggle="yes">J Extracell Vesicles</italic></source>. <year>2020</year>;<volume>9</volume>:<fpage>1692401</fpage>. doi:<pub-id pub-id-type="doi">10.1080/20013078.2019.1692401</pub-id><pub-id pub-id-type="pmid">31807236</pub-id><pub-id pub-id-type="pmcid">PMC6882439</pub-id></mixed-citation></ref><ref id="cit0086"><label>86.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Langevin</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>Kuhnell</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Orr-Asman</surname><given-names>MA</given-names></string-name>, et al. <article-title>Balancing yield, purity and practicality: a modified differential ultracentrifugation protocol for efficient isolation of small extracellular vesicles from human serum</article-title>. <source><italic toggle="yes">RNA Biol</italic></source>. <year>2019</year>;<volume>16</volume>:<fpage>5</fpage>&#8211;<lpage>12</lpage>. doi:<pub-id pub-id-type="doi">10.1080/15476286.2018.1564465</pub-id><pub-id pub-id-type="pmid">30604646</pub-id><pub-id pub-id-type="pmcid">PMC6380284</pub-id></mixed-citation></ref><ref id="cit0087"><label>87.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Ter-ovanesyan</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Norman</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lazarovits</surname><given-names>R</given-names></string-name>, et al. <article-title>Framework for rapid comparison of extracellular vesicle isolation methods</article-title>. <source><italic toggle="yes">Elife</italic></source>. <year>2021</year>;<volume>10</volume>:<fpage>e70725</fpage>. doi:<pub-id pub-id-type="doi">10.7554/eLife.70725</pub-id><pub-id pub-id-type="pmid">34783650</pub-id><pub-id pub-id-type="pmcid">PMC8651285</pub-id></mixed-citation></ref><ref id="cit0088"><label>88.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Kamei</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Nishimura</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Matsumoto</surname><given-names>A</given-names></string-name>, et al. <article-title>Comparative study of commercial protocols for high recovery of high-purity mesenchymal stem cell-derived extracellular vesicle isolation and their efficient labeling with fluorescent dyes</article-title>. <source><italic toggle="yes">Nanomedicine</italic></source>. <year>2021</year>;<volume>35</volume>:<fpage>102396</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.nano.2021.102396</pub-id><pub-id pub-id-type="pmid">33864911</pub-id></mixed-citation></ref><ref id="cit0089"><label>89.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Mondal</surname><given-names>SK</given-names></string-name>, <string-name name-style="western"><surname>Whiteside</surname><given-names>TL</given-names></string-name>. <article-title>Immunoaffinity-Based Isolation of Melanoma Cell-Derived and T Cell-Derived Exosomes from Plasma of Melanoma Patients</article-title>. <source><italic toggle="yes">Methods Mol Biol</italic></source>. <year>2021</year>;<volume>2265</volume>:<fpage>305</fpage>&#8211;<lpage>321</lpage>. doi:<pub-id pub-id-type="doi">10.1007/978-1-0716-1205-7_23</pub-id><pub-id pub-id-type="pmid">33704724</pub-id><pub-id pub-id-type="pmcid">PMC9113061</pub-id></mixed-citation></ref><ref id="cit0090"><label>90.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Linares</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Gounou</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Arraud</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Brisson</surname><given-names>AR</given-names></string-name>. <article-title>High-speed centrifugation induces aggregation of extracellular vesicles</article-title>. <source><italic toggle="yes">J Extracell Vesicles</italic></source>. <year>2015</year>;<volume>4</volume>:<fpage>29509</fpage>. doi:<pub-id pub-id-type="doi">10.3402/jev.v4.29509</pub-id><pub-id pub-id-type="pmid">26700615</pub-id><pub-id pub-id-type="pmcid">PMC4689953</pub-id></mixed-citation></ref><ref id="cit0091"><label>91.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Benedikter</surname><given-names>BJ</given-names></string-name>, <string-name name-style="western"><surname>Bouwman</surname><given-names>FG</given-names></string-name>, <string-name name-style="western"><surname>Vajen</surname><given-names>T</given-names></string-name>, et al. <article-title>Ultrafiltration combined with size exclusion chromatography efficiently isolates extracellular vesicles from cell culture media for compositional and functional studies</article-title>. <source><italic toggle="yes">Sci Rep</italic></source>. <year>2017</year>;<volume>7</volume>:<fpage>15297</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41598-017-15717-7</pub-id><pub-id pub-id-type="pmid">29127410</pub-id><pub-id pub-id-type="pmcid">PMC5681555</pub-id></mixed-citation></ref><ref id="cit0092"><label>92.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Turner</surname><given-names>NP</given-names></string-name>, <string-name name-style="western"><surname>Abeysinghe</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Kwan Cheung</surname><given-names>KA</given-names></string-name>, et al. <article-title>A Comparison of Blood Plasma Small Extracellular Vesicle Enrichment Strategies for Proteomic Analysis</article-title>. <source><italic toggle="yes">Proteomes</italic></source>. <year>2022</year>;<volume>10</volume>:<fpage>19</fpage>. doi:<pub-id pub-id-type="doi">10.3390/proteomes10020019</pub-id><pub-id pub-id-type="pmid">35736799</pub-id><pub-id pub-id-type="pmcid">PMC9229025</pub-id></mixed-citation></ref><ref id="cit0093"><label>93.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Mark</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Haeberle</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Roth</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>von Stetten</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Zengerle</surname><given-names>R</given-names></string-name>. <article-title>Microfluidic lab-on-A-chip platforms: requirements, characteristics and applications</article-title>. <source><italic toggle="yes">Chem Soc Rev</italic></source>. <year>2010</year>;<volume>39</volume>:<fpage>1153</fpage>&#8211;<lpage>1182</lpage>. doi:<pub-id pub-id-type="doi">10.1039/b820557b</pub-id><pub-id pub-id-type="pmid">20179830</pub-id></mixed-citation></ref><ref id="cit0094"><label>94.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Kang</surname><given-names>YT</given-names></string-name>, <string-name name-style="western"><surname>Niu</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Hadlock</surname><given-names>T</given-names></string-name>, et al. <article-title>On-Chip Biogenesis of Circulating NK Cell-Derived Exosomes in Non-Small Cell Lung Cancer Exhibits Antitumoral Activity</article-title>. <source><italic toggle="yes">Adv Sci</italic></source>. <year>2021</year>;<volume>8</volume>:<fpage>2003747</fpage>. doi:<pub-id pub-id-type="doi">10.1002/advs.202003747</pub-id><pub-id pub-id-type="pmcid">PMC7967048</pub-id><pub-id pub-id-type="pmid">33747745</pub-id></mixed-citation></ref><ref id="cit0095"><label>95.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Bathini</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Pakkiriswami</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ouellette</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Ghosh</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Packirisamy</surname><given-names>M</given-names></string-name>. <article-title>Magnetic particle based liquid biopsy chip for isolation of extracellular vesicles and characterization by gene amplification</article-title>. <source><italic toggle="yes">Biosens Bioelectron</italic></source>. <year>2021</year>;<volume>194</volume>:<fpage>113585</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bios.2021.113585</pub-id><pub-id pub-id-type="pmid">34517262</pub-id></mixed-citation></ref><ref id="cit0096"><label>96.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Zhang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Guan</surname><given-names>M</given-names></string-name>, et al. <article-title>Isolation of circulating exosomes and identification of exosomal PD-L1 for predicting immunotherapy response</article-title>. <source><italic toggle="yes">Nanoscale</italic></source>. <year>2022</year>;<volume>14</volume>:<fpage>8995</fpage>&#8211;<lpage>9003</lpage>. doi:<pub-id pub-id-type="doi">10.1039/d2nr00829g</pub-id><pub-id pub-id-type="pmid">35700522</pub-id></mixed-citation></ref><ref id="cit0097"><label>97.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Xiu</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Mou</surname><given-names>Z</given-names></string-name>, et al. <article-title>Exosomes derived from Toxoplasma gondii stimulate an inflammatory response through JNK signaling pathway</article-title>. <source><italic toggle="yes">Nanomedicine</italic></source>. <year>2018</year>;<volume>13</volume>:<fpage>1157</fpage>&#8211;<lpage>1168</lpage>. doi:<pub-id pub-id-type="doi">10.2217/nnm-2018-0035</pub-id><pub-id pub-id-type="pmid">29542367</pub-id></mixed-citation></ref><ref id="cit0098"><label>98.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Tang</surname><given-names>YT</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>YY</given-names></string-name>, <string-name name-style="western"><surname>Zheng</surname><given-names>L</given-names></string-name>, et al. <article-title>Comparison of isolation methods of exosomes and exosomal RNA from cell culture medium and serum</article-title>. <source><italic toggle="yes">Int J Mol Med</italic></source>. <year>2017</year>;<volume>40</volume>:<fpage>834</fpage>&#8211;<lpage>844</lpage>. doi:<pub-id pub-id-type="doi">10.3892/ijmm.2017.3080</pub-id><pub-id pub-id-type="pmid">28737826</pub-id><pub-id pub-id-type="pmcid">PMC5548045</pub-id></mixed-citation></ref><ref id="cit0099"><label>99.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Miron</surname><given-names>RJ</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>. <article-title>Understanding exosomes: part 1-Characterization, quantification and isolation techniques</article-title>. <source><italic toggle="yes">Periodontol 2000</italic></source>. <year>2023</year>;<volume>94</volume>:<fpage>231</fpage>&#8211;<lpage>256</lpage>. doi:<pub-id pub-id-type="doi">10.1111/prd.12520</pub-id><pub-id pub-id-type="pmid">37740431</pub-id></mixed-citation></ref><ref id="cit0100"><label>100.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Alt&#305;nta&#351;</surname><given-names>&#214;</given-names></string-name>, <string-name name-style="western"><surname>Saylan</surname><given-names>Y</given-names></string-name>. <article-title>Exploring the Versatility of Exosomes: a Review on Isolation, Characterization, Detection Methods, and Diverse Applications</article-title>. <source><italic toggle="yes">Anal Chem</italic></source>. <year>2023</year>;<volume>95</volume>:<fpage>16029</fpage>&#8211;<lpage>16048</lpage>. doi:<pub-id pub-id-type="doi">10.1021/acs.analchem.3c02224</pub-id><pub-id pub-id-type="pmid">37874907</pub-id></mixed-citation></ref><ref id="cit0101"><label>101.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Kim</surname><given-names>DK</given-names></string-name>, <string-name name-style="western"><surname>Kang</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>OY</given-names></string-name>, et al. <article-title>EVpedia: an integrated database of high-throughput data for systemic analyses of extracellular vesicles</article-title>. <source><italic toggle="yes">J Extracell Vesicles</italic></source>. <year>2013</year>;<volume>2</volume>. doi:<pub-id pub-id-type="doi">10.3402/jev.v2i0.20384</pub-id><pub-id pub-id-type="pmcid">PMC3760654</pub-id><pub-id pub-id-type="pmid">24009897</pub-id></mixed-citation></ref><ref id="cit0102"><label>102.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Ram&#237;rez-Flores</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Cruz-Mir&#243;n</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Mondrag&#243;n-Castel&#225;n</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Gonz&#225;lez-Pozos</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>R&#237;os-Castro</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Mondrag&#243;n-Flores</surname><given-names>R</given-names></string-name>. <article-title>Proteomic and structural characterization of self-assembled vesicles from excretion/secretion products of Toxoplasma gondii</article-title>. <source><italic toggle="yes">J Proteomics</italic></source>. <year>2019</year>;<volume>208</volume>:<fpage>103490</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jprot.2019.103490</pub-id><pub-id pub-id-type="pmid">31434009</pub-id></mixed-citation></ref><ref id="cit0103"><label>103.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Quiarim</surname><given-names>TM</given-names></string-name>, <string-name name-style="western"><surname>Maia</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>da Cruz</surname><given-names>AB</given-names></string-name>, <string-name name-style="western"><surname>Taniwaki</surname><given-names>NN</given-names></string-name>, <string-name name-style="western"><surname>Namiyama</surname><given-names>GM</given-names></string-name>, <string-name name-style="western"><surname>Pereira-Chioccola</surname><given-names>VL</given-names></string-name>. <article-title>Characterization of extracellular vesicles isolated from types I, II and III strains of Toxoplasma gondii</article-title>. <source><italic toggle="yes">Acta Trop</italic></source>. <year>2021</year>;<volume>219</volume>:<fpage>105915</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.actatropica.2021.105915</pub-id><pub-id pub-id-type="pmid">33861971</pub-id></mixed-citation></ref><ref id="cit0104"><label>104.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Pope</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>L&#228;sser</surname><given-names>C</given-names></string-name>. <article-title>Toxoplasma gondii infection of fibroblasts causes the production of exosome-like vesicles containing a unique array of mRNA and miRNA transcripts compared to serum starvation</article-title>. <source><italic toggle="yes">J Extracell Vesicles</italic></source>. <year>2013</year>;<volume>2</volume>. doi:<pub-id pub-id-type="doi">10.3402/jev.v2i0.22484</pub-id><pub-id pub-id-type="pmcid">PMC3862870</pub-id><pub-id pub-id-type="pmid">24363837</pub-id></mixed-citation></ref><ref id="cit0105"><label>105.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Kim</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Jung</surname><given-names>BK</given-names></string-name>, <string-name name-style="western"><surname>Cho</surname><given-names>J</given-names></string-name>, et al. <article-title>Exosomes Secreted by Toxoplasma gondii-Infected L6 Cells: their Effects on Host Cell Proliferation and Cell Cycle Changes</article-title>. <source><italic toggle="yes">Korean J Parasitol</italic></source>. <year>2016</year>;<volume>54</volume>:<fpage>147</fpage>&#8211;<lpage>154</lpage>. doi:<pub-id pub-id-type="doi">10.3347/kjp.2016.54.2.147</pub-id><pub-id pub-id-type="pmid">27180572</pub-id><pub-id pub-id-type="pmcid">PMC4870968</pub-id></mixed-citation></ref><ref id="cit0106"><label>106.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Keerthikumar</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Chisanga</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Ariyaratne</surname><given-names>D</given-names></string-name>, et al. <article-title>ExoCarta: a Web-Based Compendium of Exosomal Cargo</article-title>. <source><italic toggle="yes">J Mol Biol</italic></source>. <year>2016</year>;<volume>428</volume>:<fpage>688</fpage>&#8211;<lpage>692</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jmb.2015.09.019</pub-id><pub-id pub-id-type="pmid">26434508</pub-id><pub-id pub-id-type="pmcid">PMC4783248</pub-id></mixed-citation></ref><ref id="cit0107"><label>107.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Zhang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Freitas</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>HS</given-names></string-name>, et al. <article-title>Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation</article-title>. <source><italic toggle="yes">Nat Cell Biol</italic></source>. <year>2018</year>;<volume>20</volume>:<fpage>332</fpage>&#8211;<lpage>343</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41556-018-0040-4</pub-id><pub-id pub-id-type="pmid">29459780</pub-id><pub-id pub-id-type="pmcid">PMC5931706</pub-id></mixed-citation></ref><ref id="cit0108"><label>108.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Johnstone</surname><given-names>RM</given-names></string-name>, <string-name name-style="western"><surname>Adam</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hammond</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Orr</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Turbide</surname><given-names>C</given-names></string-name>. <article-title>Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes)</article-title>. <source><italic toggle="yes">J Biol Chem</italic></source>. <year>1987</year>;<volume>262</volume>:<fpage>9412</fpage>&#8211;<lpage>9420</lpage>.<pub-id pub-id-type="pmid">3597417</pub-id></mixed-citation></ref><ref id="cit0109"><label>109.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Denzer</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>van Eijk</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Kleijmeer</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Jakobson</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>de Groot</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Geuze</surname><given-names>HJ</given-names></string-name>. <article-title>Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface</article-title>. <source><italic toggle="yes">J Immunol</italic></source>. <year>2000</year>;<volume>165</volume>:<fpage>1259</fpage>&#8211;<lpage>1265</lpage>. doi:<pub-id pub-id-type="doi">10.4049/jimmunol.165.3.1259</pub-id><pub-id pub-id-type="pmid">10903724</pub-id></mixed-citation></ref><ref id="cit0110"><label>110.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>M&#246;bius</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Ohno-Iwashita</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>van Donselaar</surname><given-names>EG</given-names></string-name>, et al. <article-title>Immunoelectron microscopic localization of cholesterol using biotinylated and non-cytolytic perfringolysin O</article-title>. <source><italic toggle="yes">J Histochem Cytochem</italic></source>. <year>2002</year>;<volume>50</volume>:<fpage>43</fpage>&#8211;<lpage>55</lpage>. doi:<pub-id pub-id-type="doi">10.1177/002215540205000105</pub-id><pub-id pub-id-type="pmid">11748293</pub-id></mixed-citation></ref><ref id="cit0111"><label>111.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Brecht</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Carruthers</surname><given-names>VB</given-names></string-name>, <string-name name-style="western"><surname>Ferguson</surname><given-names>DJ</given-names></string-name>, et al. <article-title>The toxoplasma micronemal protein MIC4 is an adhesin composed of six conserved apple domains</article-title>. <source><italic toggle="yes">J Biol Chem</italic></source>. <year>2001</year>;<volume>276</volume>:<fpage>4119</fpage>&#8211;<lpage>4127</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M008294200</pub-id><pub-id pub-id-type="pmid">11053441</pub-id></mixed-citation></ref><ref id="cit0112"><label>112.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Jewett</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Sibley</surname><given-names>LD</given-names></string-name>. <article-title>The toxoplasma proteins MIC2 and M2AP form a hexameric complex necessary for intracellular survival</article-title>. <source><italic toggle="yes">J Biol Chem</italic></source>. <year>2004</year>;<volume>279</volume>:<fpage>9362</fpage>&#8211;<lpage>9369</lpage>. doi:<pub-id pub-id-type="doi">10.1074/jbc.M312590200</pub-id><pub-id pub-id-type="pmid">14670959</pub-id></mixed-citation></ref><ref id="cit0113"><label>113.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Clough</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Frickel</surname><given-names>EM</given-names></string-name>. <article-title>The Toxoplasma Parasitophorous Vacuole: an Evolving Host-Parasite Frontier</article-title>. <source><italic toggle="yes">Trends Parasitol</italic></source>. <year>2017</year>;<volume>33</volume>:<fpage>473</fpage>&#8211;<lpage>488</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pt.2017.02.007</pub-id><pub-id pub-id-type="pmid">28330745</pub-id></mixed-citation></ref><ref id="cit0114"><label>114.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Alexander</surname><given-names>DL</given-names></string-name>, <string-name name-style="western"><surname>Mital</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ward</surname><given-names>GE</given-names></string-name>, <string-name name-style="western"><surname>Bradley</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Boothroyd</surname><given-names>JC</given-names></string-name>. <article-title>Identification of the moving junction complex of Toxoplasma gondii: a collaboration between distinct secretory organelles</article-title>. <source><italic toggle="yes">PLoS Pathog</italic></source>. <year>2005</year>; <volume>1</volume>:<fpage>e17</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.ppat.0010017</pub-id><pub-id pub-id-type="pmid">16244709</pub-id><pub-id pub-id-type="pmcid">PMC1262624</pub-id></mixed-citation></ref><ref id="cit0115"><label>115.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Maia</surname><given-names>MM</given-names></string-name>, <string-name name-style="western"><surname>da Cruz</surname><given-names>AB</given-names></string-name>, <string-name name-style="western"><surname>Taniwaki</surname><given-names>NN</given-names></string-name>, et al. <article-title>Immunization with extracellular vesicles excreted by Toxoplasma gondii confers protection in murine infection, activating cellular and humoral responses</article-title>. <source><italic toggle="yes">Int J Parasitol</italic></source>. <year>2021</year>;<volume>51</volume>:<fpage>559</fpage>&#8211;<lpage>569</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijpara.2020.11.010</pub-id><pub-id pub-id-type="pmid">33713649</pub-id></mixed-citation></ref><ref id="cit0116"><label>116.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Lu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wei</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Zhu</surname><given-names>S</given-names></string-name>, et al. <article-title>Exosomes Derived From Dendritic Cells Infected With Toxoplasma gondii Show Antitumoral Activity in a Mouse Model of Colorectal Cancer</article-title>. <source><italic toggle="yes">Front Oncol</italic></source>. <year>2022</year>;<volume>12</volume>:<fpage>899737</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fonc.2022.899737</pub-id><pub-id pub-id-type="pmid">35600363</pub-id><pub-id pub-id-type="pmcid">PMC9114749</pub-id></mixed-citation></ref><ref id="cit0117"><label>117.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Aline</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Bout</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Amigorena</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Roingeard</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Dimier-Poisson</surname><given-names>I</given-names></string-name>. <article-title>Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection</article-title>. <source><italic toggle="yes">Infect Immun</italic></source>. <year>2004</year>;<volume>72</volume>:<fpage>4127</fpage>&#8211;<lpage>4137</lpage>. doi:<pub-id pub-id-type="doi">10.1128/iai.72.7.4127-4137.2004</pub-id><pub-id pub-id-type="pmid">15213158</pub-id><pub-id pub-id-type="pmcid">PMC427397</pub-id></mixed-citation></ref><ref id="cit0118"><label>118.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Bhatnagar</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Shinagawa</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Castellino</surname><given-names>FJ</given-names></string-name>, <string-name name-style="western"><surname>Schorey</surname><given-names>JS</given-names></string-name>. <article-title>Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo</article-title>. <source><italic toggle="yes">Blood</italic></source>. <year>2007</year>;<volume>110</volume>:<fpage>3234</fpage>&#8211;<lpage>3244</lpage>. doi:<pub-id pub-id-type="doi">10.1182/blood-2007-03-079152</pub-id><pub-id pub-id-type="pmid">17666571</pub-id><pub-id pub-id-type="pmcid">PMC2200902</pub-id></mixed-citation></ref><ref id="cit0119"><label>119.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Beauvillain</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Juste</surname><given-names>MO</given-names></string-name>, <string-name name-style="western"><surname>Dion</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Pierre</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Dimier-Poisson</surname><given-names>I</given-names></string-name>. <article-title>Exosomes are an effective vaccine against congenital toxoplasmosis in mice</article-title>. <source><italic toggle="yes">Vaccine</italic></source>. <year>2009</year>;<volume>27</volume>:<fpage>1750</fpage>&#8211;<lpage>1757</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.vaccine.2009.01.022</pub-id><pub-id pub-id-type="pmid">19186199</pub-id></mixed-citation></ref><ref id="cit0120"><label>120.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Tawfeek</surname><given-names>GM</given-names></string-name>, <string-name name-style="western"><surname>Abou-El-Naga</surname><given-names>IF</given-names></string-name>, <string-name name-style="western"><surname>Hassan</surname><given-names>EME</given-names></string-name>, <string-name name-style="western"><surname>Sabry</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Meselhey</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Younis</surname><given-names>SS</given-names></string-name>. <article-title>Protective efficacy of Toxoplasma gondii infected cells-derived exosomes against chronic murine toxoplasmosis</article-title>. <source><italic toggle="yes">Acta Trop</italic></source>. <year>2023</year>;<volume>248</volume>:<fpage>107041</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.actatropica.2023.107041</pub-id><pub-id pub-id-type="pmid">37858877</pub-id></mixed-citation></ref><ref id="cit0121"><label>121.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Stoorvogel</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Kleijmeer</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Geuze</surname><given-names>HJ</given-names></string-name>, <string-name name-style="western"><surname>Raposo</surname><given-names>G</given-names></string-name>. <article-title>The biogenesis and functions of exosomes</article-title>. <source><italic toggle="yes">Traffic</italic></source>. <year>2002</year>;<volume>3</volume>:<fpage>321</fpage>&#8211;<lpage>330</lpage>. doi:<pub-id pub-id-type="doi">10.1034/j.1600-0854.2002.30502.x</pub-id><pub-id pub-id-type="pmid">11967126</pub-id></mixed-citation></ref><ref id="cit0122"><label>122.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Bowers</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Stevens</surname><given-names>TH</given-names></string-name>. <article-title>Protein transport from the late Golgi to the vacuole in the yeast Saccharomyces cerevisiae</article-title>. <source><italic toggle="yes">Biochim Biophys Acta</italic></source>. <year>2005</year>;<volume>1744</volume>:<fpage>438</fpage>&#8211;<lpage>454</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.bbamcr.2005.04.004</pub-id><pub-id pub-id-type="pmid">15913810</pub-id></mixed-citation></ref><ref id="cit0123"><label>123.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Gao</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Feng</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Shen</surname><given-names>Z</given-names></string-name>. <article-title>Recent developments in isolating methods for exosomes</article-title>. <source><italic toggle="yes">Front Bioeng Biotechnol</italic></source>. <year>2022</year>;<volume>10</volume>:<fpage>1100892</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fbioe.2022.1100892</pub-id><pub-id pub-id-type="pmid">36714629</pub-id><pub-id pub-id-type="pmcid">PMC9879965</pub-id></mixed-citation></ref><ref id="cit0124"><label>124.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Feng</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>WL</given-names></string-name>, <string-name name-style="western"><surname>Ye</surname><given-names>YY</given-names></string-name>, et al. <article-title>Cellular internalization of exosomes occurs through phagocytosis</article-title>. <source><italic toggle="yes">Traffic</italic></source>. <year>2010</year>;<volume>11</volume>:<fpage>675</fpage>&#8211;<lpage>687</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1600-0854.2010.01041.x</pub-id><pub-id pub-id-type="pmid">20136776</pub-id></mixed-citation></ref><ref id="cit0125"><label>125.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Fitzner</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Schnaars</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>van Rossum</surname><given-names>D</given-names></string-name>, et al. <article-title>Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis</article-title>. <source><italic toggle="yes">J Cell Sci</italic></source>. <year>2011</year>;<volume>124</volume>:<fpage>447</fpage>&#8211;<lpage>458</lpage>. doi:<pub-id pub-id-type="doi">10.1242/jcs.074088</pub-id><pub-id pub-id-type="pmid">21242314</pub-id></mixed-citation></ref><ref id="cit0126"><label>126.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Pofali</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Mondal</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Londhe</surname><given-names>V</given-names></string-name>. <article-title>Exosome as a Natural Gene Delivery Vector for Cancer Treatment</article-title>. <source><italic toggle="yes">Curr Cancer Drug Targets</italic></source>. <year>2020</year>;<volume>20</volume>:<fpage>821</fpage>&#8211;<lpage>830</lpage>. doi:<pub-id pub-id-type="doi">10.2174/1568009620666200924154149</pub-id><pub-id pub-id-type="pmid">32972340</pub-id></mixed-citation></ref><ref id="cit0127"><label>127.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Zhang</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Hu</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>L</given-names></string-name>, et al. <article-title>Engineered exosomes from different sources for cancer-targeted therapy</article-title>. <source><italic toggle="yes">Signal Transduct Target Ther</italic></source>. <year>2023</year>;<volume>8</volume>:<fpage>124</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41392-023-01382-y</pub-id><pub-id pub-id-type="pmid">36922504</pub-id><pub-id pub-id-type="pmcid">PMC10017761</pub-id></mixed-citation></ref><ref id="cit0128"><label>128.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Liu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ren</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>S</given-names></string-name>, et al. <article-title>The biology, function, and applications of exosomes in cancer</article-title>. <source><italic toggle="yes">Acta Pharm Sin B</italic></source>. <year>2021</year>;<volume>11</volume>:<fpage>2783</fpage>&#8211;<lpage>2797</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.apsb.2021.01.001</pub-id><pub-id pub-id-type="pmid">34589397</pub-id><pub-id pub-id-type="pmcid">PMC8463268</pub-id></mixed-citation></ref><ref id="cit0129"><label>129.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Zhang</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Ding</surname><given-names>L</given-names></string-name>, et al. <article-title>Trojan Horse Delivery of 4,4&#8217;-Dimethoxychalcone for Parkinsonian Neuroprotection</article-title>. <source><italic toggle="yes">Adv Sci</italic></source>. <year>2021</year>;<volume>8</volume>:<fpage>2004555</fpage>. doi:<pub-id pub-id-type="doi">10.1002/advs.202004555</pub-id><pub-id pub-id-type="pmcid">PMC8097374</pub-id><pub-id pub-id-type="pmid">33977069</pub-id></mixed-citation></ref><ref id="cit0130"><label>130.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Conroy</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Bosset</surname><given-names>JF</given-names></string-name>, <string-name name-style="western"><surname>Etienne</surname><given-names>PL</given-names></string-name>, et al. <article-title>Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, Phase 3 trial</article-title>. <source><italic toggle="yes">Lancet Oncol</italic></source>. <year>2021</year>;<volume>22</volume>:<fpage>702</fpage>&#8211;<lpage>715</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s1470-2045(21)00079-6</pub-id><pub-id pub-id-type="pmid">33862000</pub-id></mixed-citation></ref><ref id="cit0131"><label>131.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Ransom</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Wilson</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Fournier</surname><given-names>M</given-names></string-name>, et al. <article-title>Final results of Australasian Gastrointestinal Trials Group Arctic study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines</article-title>. <source><italic toggle="yes">Ann Oncol</italic></source>. <year>2014</year>;<volume>25</volume>:<fpage>117</fpage>&#8211;<lpage>121</lpage>. doi:<pub-id pub-id-type="doi">10.1093/annonc/mdt479</pub-id><pub-id pub-id-type="pmid">24299960</pub-id></mixed-citation></ref><ref id="cit0132"><label>132.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Eldar-Boock</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Polyak</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Scomparin</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Satchi-Fainaro</surname><given-names>R</given-names></string-name>. <article-title>Nano-sized polymers and liposomes designed to deliver combination therapy for cancer</article-title>. <source><italic toggle="yes">Curr Opin Biotechnol</italic></source>. <year>2013</year>;<volume>24</volume>:<fpage>682</fpage>&#8211;<lpage>689</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.copbio.2013.04.014</pub-id><pub-id pub-id-type="pmid">23726153</pub-id></mixed-citation></ref><ref id="cit0133"><label>133.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Basso</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Miranda</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Nunes</surname><given-names>S</given-names></string-name>, et al. <article-title>Hydrogel-Based Drug Delivery Nanosystems for the Treatment of Brain Tumors</article-title>. <source><italic toggle="yes">Gels</italic></source>. <year>2018</year>;<volume>4</volume>:<fpage>62</fpage>. doi:<pub-id pub-id-type="doi">10.3390/gels4030062</pub-id><pub-id pub-id-type="pmid">30674838</pub-id><pub-id pub-id-type="pmcid">PMC6209281</pub-id></mixed-citation></ref><ref id="cit0134"><label>134.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Yang</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ou</surname><given-names>H</given-names></string-name>, et al. <article-title>Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application</article-title>. <source><italic toggle="yes">J Nanobiotechnology</italic></source>. <year>2024</year>;<volume>22</volume>:<fpage>41</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12951-024-02298-7</pub-id><pub-id pub-id-type="pmid">38281957</pub-id><pub-id pub-id-type="pmcid">PMC10823703</pub-id></mixed-citation></ref><ref id="cit0135"><label>135.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Sercombe</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Veerati</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Moheimani</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>SY</given-names></string-name>, <string-name name-style="western"><surname>Sood</surname><given-names>AK</given-names></string-name>, <string-name name-style="western"><surname>Hua</surname><given-names>S</given-names></string-name>. <article-title>Advances and Challenges of Liposome Assisted Drug Delivery</article-title>. <source><italic toggle="yes">Front Pharmacol</italic></source>. <year>2015</year>;<volume>6</volume>:<fpage>286</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fphar.2015.00286</pub-id><pub-id pub-id-type="pmid">26648870</pub-id><pub-id pub-id-type="pmcid">PMC4664963</pub-id></mixed-citation></ref><ref id="cit0136"><label>136.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>van der Koog</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Gandek</surname><given-names>TB</given-names></string-name>, <string-name name-style="western"><surname>Nagelkerke</surname><given-names>A</given-names></string-name>. <article-title>Liposomes and Extracellular Vesicles as Drug Delivery Systems: a Comparison of Composition, Pharmacokinetics, and Functionalization</article-title>. <source><italic toggle="yes">Adv Healthc Mater</italic></source>. <year>2022</year>; <volume>11</volume>:<fpage>e2100639</fpage>. doi:<pub-id pub-id-type="doi">10.1002/adhm.202100639</pub-id><pub-id pub-id-type="pmid">34165909</pub-id><pub-id pub-id-type="pmcid">PMC11468589</pub-id></mixed-citation></ref><ref id="cit0137"><label>137.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Turturici</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Tinnirello</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Sconzo</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Geraci</surname><given-names>F</given-names></string-name>. <article-title>Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages</article-title>. <source><italic toggle="yes">Am J Physiol Cell Physiol</italic></source>. <year>2014</year>; <volume>306</volume>:<fpage>C621</fpage>&#8211;<lpage>633</lpage>. doi:<pub-id pub-id-type="doi">10.1152/ajpcell.00228.2013</pub-id><pub-id pub-id-type="pmid">24452373</pub-id></mixed-citation></ref><ref id="cit0138"><label>138.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Xu</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Xiong</surname><given-names>X</given-names></string-name>, et al. <article-title>A near-infrared light-responsive extracellular vesicle as a&#8221;Trojan horse&#8221; for tumor deep penetration and imaging-guided therapy</article-title>. <source><italic toggle="yes">Biomaterials</italic></source>. <year>2021</year>;<volume>269</volume>:<fpage>120647</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biomaterials.2020.120647</pub-id><pub-id pub-id-type="pmid">33450584</pub-id></mixed-citation></ref><ref id="cit0139"><label>139.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Roth</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Agemy</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Kotamraju</surname><given-names>VR</given-names></string-name>, et al. <article-title>Transtumoral targeting enabled by a novel neuropilin-binding peptide</article-title>. <source><italic toggle="yes">Oncogene</italic></source>. <year>2012</year>;<volume>31</volume>:<fpage>3754</fpage>&#8211;<lpage>3763</lpage>. doi:<pub-id pub-id-type="doi">10.1038/onc.2011.537</pub-id><pub-id pub-id-type="pmid">22179825</pub-id></mixed-citation></ref><ref id="cit0140"><label>140.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Ishiguro</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Yan</surname><given-names>IK</given-names></string-name>, <string-name name-style="western"><surname>Lewis-Tuffin</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Patel</surname><given-names>T</given-names></string-name>. <article-title>Targeting Liver Cancer Stem Cells Using Engineered Biological Nanoparticles for the Treatment of Hepatocellular Cancer</article-title>. <source><italic toggle="yes">Hepatol Commun</italic></source>. <year>2020</year>;<volume>4</volume>:<fpage>298</fpage>&#8211;<lpage>313</lpage>. doi:<pub-id pub-id-type="doi">10.1002/hep4.1462</pub-id><pub-id pub-id-type="pmid">32025612</pub-id><pub-id pub-id-type="pmcid">PMC6996342</pub-id></mixed-citation></ref><ref id="cit0141"><label>141.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Tian</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Song</surname><given-names>J</given-names></string-name>, et al. <article-title>A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy</article-title>. <source><italic toggle="yes">Biomaterials</italic></source>. <year>2014</year>;<volume>35</volume>:<fpage>2383</fpage>&#8211;<lpage>2390</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.biomaterials.2013.11.083</pub-id><pub-id pub-id-type="pmid">24345736</pub-id></mixed-citation></ref><ref id="cit0142"><label>142.</label><mixed-citation publication-type="journal"><string-name name-style="western"><surname>Wang</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Y</given-names></string-name>, et al. <article-title>Engineering a HEK-293T exosome-based delivery platform for efficient tumor-targeting chemotherapy/internal irradiation combination therapy</article-title>. <source><italic toggle="yes">J Nanobiotechnology</italic></source>. <year>2022</year>;<volume>20</volume>:<fpage>247</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12951-022-01462-1</pub-id><pub-id pub-id-type="pmid">35642064</pub-id><pub-id pub-id-type="pmcid">PMC9153154</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>